https://www.sehk-wiki.org/api.php?action=feedcontributions&feedformat=atom&user=Calise 2026-04-22T21:02:09Z User contributions MediaWiki 1.43.0 https://www.sehk-wiki.org/index.php?title=Category:Proton_Pump_Inhibitors_(PPI)&diff=5087 2025-01-06T08:49:13Z

<p>Calise: </p> <hr /> <div>[[Category: Gastrointestinal Drug]] <br /> '''Proton Pump Inhibitors (PPI)''' (中文: [[:Category: 質子泵抑制劑 (PPI) | 質子泵抑制劑 (PPI)]])</div>

Calise https://www.sehk-wiki.org/index.php?title=Category:Proton_Pump_Inhibitors_(PPI)&diff=5086 2025-01-06T08:49:03Z

<p>Calise: </p> <hr /> <div>[[Category: Gastrointestinal Drug]] <br /> '''EXTRA WORDS!!<br /> '''Proton Pump Inhibitors (PPI)''' (中文: [[:Category: 質子泵抑制劑 (PPI) | 質子泵抑制劑 (PPI)]])</div>

Calise https://www.sehk-wiki.org/index.php?title=Category:Proton_Pump_Inhibitors_(PPI)&diff=5085 2025-01-06T07:33:41Z

<p>Calise: </p> <hr /> <div>[[Category: Gastrointestinal Drug]] <br /> '''Proton Pump Inhibitors (PPI)''' (中文: [[:Category: 質子泵抑制劑 (PPI) | 質子泵抑制劑 (PPI)]])</div>

Calise https://www.sehk-wiki.org/index.php?title=Category:Proton_Pump_Inhibitors_(PPI)&diff=5084 2025-01-06T07:33:23Z

<p>Calise: </p> <hr /> <div>[[Category: Gastrointestinal Drug]] <br /> '''Proton Pump Inhibitors (PPI)''' (中文: [[:Category: 質子泵抑制劑 (PPI) | 質子泵抑制劑 (PPI)]])<br /> <br /> <br /> '''some extra words</div>

Calise https://www.sehk-wiki.org/index.php?title=Category:Drugs&diff=5083 2025-01-06T07:31:25Z

<p>Calise: </p> <hr /> <div>{|<br /> |&lt;div class=&quot;toccolours mw-collapsible mw-collapsed&quot;&gt;[[:Category:Anticoagulant Drug | Anticoagulant Drug]]<br /> &lt;div class=&quot;mw-collapsible-content&quot;&gt;<br /> *[[:Category: Coumarin Anticoagulant | Coumarin Anticoagulant]]<br /> *[[:Category: Direct Factor Xa inhibitor | Direct Factor Xa inhibitor]]<br /> *[[:Category: Direct Thrombin Inhibitor | Direct Thrombin Inhibitor]]<br /> &lt;/div&gt;<br /> &lt;/div&gt;<br /> |}<br /> <br /> {|<br /> |&lt;div class=&quot;toccolours mw-collapsible mw-collapsed&quot;&gt;[[:Category:Anticonvulsant | Anticonvulsant]]<br /> &lt;div class=&quot;mw-collapsible-content&quot;&gt;<br /> *[[Carbamazepine]]<br /> *[[Gabapentin]]<br /> *[[Levetiracetam]]<br /> *[[Oxcarbamzepine]]<br /> *[[Phenobarbital]]<br /> *[[Phenytoin]]<br /> *[[Pregabalin]]<br /> *[[Topiramate]]<br /> *[[Valproate]]<br /> *[[Vigabatrin]]<br /> &lt;/div&gt;<br /> &lt;/div&gt;<br /> |}<br /> <br /> {|<br /> |&lt;div class=&quot;toccolours mw-collapsible mw-collapsed&quot;&gt;[[:Category: Antidementia Drug | Antidementia Drug]]<br /> &lt;div class=&quot;mw-collapsible-content&quot;&gt;<br /> *[[:Category: Acetylcholinesterase inhibitor | Acetylcholinesterase Inhibitor]]<br /> *[[:Category: NMDA receptor antagonist | NMDA Receptor Antagonist]]<br /> &lt;/div&gt;<br /> &lt;/div&gt;<br /> |}<br /> <br /> {|<br /> |&lt;div class=&quot;toccolours mw-collapsible mw-collapsed&quot;&gt;[[:Category:Antidepressant Drug | Antidepressants Drug]]<br /> &lt;div class=&quot;mw-collapsible-content&quot;&gt;<br /> *[[:Category: Atypical antidepressants | Atypical Antidepressants]]<br /> *[[:Category: Selective serotonin reuptake inhibitor | Selective Serotonin Reuptake Inhibitors, SSRI]]<br /> *[[:Category: Serotonin-norepinephrine reuptake inhibitor | Serotonin-Norepinephrine Reuptake Inhibitors, SNRIs]]<br /> *[[:Category: Tricyclic antiperessant drug | Tricyclic Antidepressant Drug, TCA]]<br /> &lt;/div&gt;<br /> &lt;/div&gt;<br /> |}<br /> <br /> {|<br /> |&lt;div class=&quot;toccolours mw-collapsible mw-collapsed&quot;&gt;[[:Category:Antidiabetic Drug | Antidiabetic Drug]]<br /> &lt;div class=&quot;mw-collapsible-content&quot;&gt;<br /> *[[:Category: Alpha-glucosidase inhibitors | Alpha-glucosidase inhibitors]]<br /> *[[:Category: Biguanide | Biguanide]]<br /> *[[:Category: Dipeptidyl peptidase-4 (DPP-4) inhibitor | Dipeptidyl peptidase-4 (DPP-4) inhibitor]]<br /> *[[:Category: Sodium-glucose co-transporter 2 (SGLT2) inhibitor | Sodium-glucose co-transporter 2 (SGLT2) inhibitor]]<br /> *[[:Category: Sulfonylureas | Sulfonylureas]]<br /> *[[:Category: Thiazolidinedione | Thiazolidinedione]]<br /> &lt;/div&gt;<br /> &lt;/div&gt;<br /> |}<br /> <br /> {|<br /> |&lt;div class=&quot;toccolours mw-collapsible mw-collapsed&quot;&gt;[[:Category:Antibiotics | Antibiotics]]<br /> &lt;div class=&quot;mw-collapsible-content&quot;&gt;<br /> *[[:Category: Beta-Lactam Antibiotics | β-Lactam Antibiotics]]<br /> *[[:Category: First Generation Cephalosporin Antibiotic | First-Generation Cephalosporin Antibiotic]]<br /> *[[:Category: Second Generation Cephalosporin Antibiotic | Second-Generation Cephalosporin Antibiotic]]<br /> *[[:Category: Third Generation Cephalosporin Antibiotic | Third-Generation Cephalosporin Antibiotic]]<br /> *[[:Category: Carbapenem | Carbapenem]]<br /> *[[:Category: Fluoroquinolone | Fluoroquinolone]]<br /> &lt;/div&gt;<br /> &lt;/div&gt;<br /> |}<br /> <br /> {|<br /> |&lt;div class=&quot;toccolours mw-collapsible mw-collapsed&quot;&gt;[[:Category:Antiparkinsonian Drug | Antiparkinsonian Drug]]<br /> &lt;div class=&quot;mw-collapsible-content&quot;&gt;<br /> *[[:Category: Dopamine D2 receptor agonist | Dopamine D2 Receptor Agonist]]<br /> *[[:Category: Dopaminergic Antiparkinsonian agent | Dopaminergic Antiparkinsonian Agent]]<br /> *[[:Category: Monoamine oxidase B inhibitor | Monoamine Oxidase B Inhibitor, MAO-B Inhibitor]]<br /> &lt;/div&gt;<br /> &lt;/div&gt;<br /> |}<br /> <br /> {|<br /> |&lt;div class=&quot;toccolours mw-collapsible mw-collapsed&quot;&gt;[[:Category:Antipsychotic Drug | Antipsychotic Drug]]<br /> &lt;div class=&quot;mw-collapsible-content&quot;&gt;<br /> *[[:Category: Atypical antipsychotic | Atypical Antipsychotic]]<br /> *[[:Category: Typical Antipsychotic | Typical Antipsychotic]]<br /> &lt;/div&gt;<br /> &lt;/div&gt;<br /> |}<br /> <br /> {|<br /> |&lt;div class=&quot;toccolour mw-collapsible mw-collapsed&quot;&gt;[[:Category: Benzodiazepine | Benzodiazepines, BDZs]]<br /> &lt;div class=&quot;mw-collapsible-content&quot;&gt;<br /> *[[Alprazolam]]<br /> *[[Bromazepam]]<br /> *[[Clobazam]]<br /> *[[Clonazepam]]<br /> *[[Diazepam]]<br /> *[[Lorazepam]]<br /> *[[Midazolam]]<br /> *[[Nitrazepam]]<br /> *[[Triazolam]]<br /> &lt;/div&gt;<br /> &lt;/div&gt;<br /> |}<br /> <br /> {|<br /> |&lt;div class=&quot;toccolours mw-collapsible mw-collapsed&quot;&gt;[[:Category:Cardiovascular Drug | Cardiovascular Drug]]<br /> &lt;div class=&quot;mw-collapsible-content&quot;&gt; <br /> Although very diverse, cardiovascular drugs can be broadly classified according to their pharmacological action. Basic details of the major groups, together with lists of the drugs are described as follow:<br /> *[[:Category: ACE inhibitors | Angiotensin Converting Enzyme Inhibitors, ACEI]]<br /> *[[:Category: Alpha blockers | α-Blockers]]<br /> *[[:Category: Angiotensin II receptor Blockers ARB | Angiotensin II Receptor Blockers, ARB]]<br /> *[[:Category: Antiarrhythmics | Antiarrhythmics]]<br /> *[[:Category: Antiplatelet drugs | Antiplatelet drugs]]<br /> *[[:Category: Beta blockers | β-Blockers]]<br /> *[[:Category: Calcium-channel Blocker, CCB | Calcium Channel Blocker, CCB]]<br /> *[[:Category: Centrally acting antihypertensives | Centrally Acting Antihypertensives]]<br /> *[[:Category: Diuretics | Diuretics]]<br /> *[[:Category: Lipid regulating drugs | Lipid Regulating Drugs]]<br /> *[[:Category: Nitrates | Nitrates]]<br /> *[[:Category: Vasodilators | Vasodilators]]<br /> &lt;/div&gt;<br /> &lt;/div&gt;<br /> |}<br /> <br /> {|<br /> |&lt;div class=&quot;toccolour mw-collapsible mw-collapsed&quot;&gt;[[:Category: Gastrointestinal Drug | Gastrointestinal Drug]]<br /> &lt;div class=&quot;mw-collapsible-content&quot;&gt;<br /> *[[:Category: Antacids | Antacids]]<br /> *[[:Category: H2 receptor antagonist | H&lt;sub&gt;2&lt;/sub&gt; Receptor Antagonist]]<br /> *[[:Category: Proton Pump Inhibitors (PPI) | Proton Pump Inhibitor, PPI]]<br /> &lt;/div&gt;<br /> &lt;/div&gt;<br /> |}<br /> <br /> {|<br /> |&lt;div class=&quot;toccolour mw-collapsible mw-collapsed&quot;&gt;[[:Category: Z-hypnotics | Hypnotics, Non-benzodiazepine GABA&lt;sub&gt;A&lt;/sub&gt; agonists]]<br /> &lt;div class=&quot;mw-collapsible-content&quot;&gt;<br /> *[[Zolpidem]]<br /> *[[Zopiclone]]<br /> &lt;/div&gt;<br /> &lt;/div&gt;<br /> |}<br /> <br /> {|<br /> |&lt;div class=&quot;toccolour mw-collapsible mw-collapsed&quot;&gt;[[:Category: PG Analogs and NSAIDs | PG Analogs &amp; NSAIDs]]<br /> &lt;div class=&quot;mw-collapsible-content&quot;&gt;<br /> *[[:Category: COX-2 inhibitor | COX-2 Inhibitors]]<br /> *[[:Category: tNSAID | Traditional NSAID, tNSAIDs]]<br /> *[[:Category: Other NSAID | Other NSAIDs]]<br /> &lt;/div&gt;<br /> &lt;/div&gt;<br /> |}</div>

Calise https://www.sehk-wiki.org/index.php?title=Category:Drugs&diff=5082 2025-01-06T07:30:40Z

<p>Calise: </p> <hr /> <div>{|<br /> |&lt;div class=&quot;toccolours mw-collapsible mw-collapsed&quot;&gt;[[:Category:Anticoagulant Drug | Anticoagulant Drug]]<br /> &lt;div class=&quot;mw-collapsible-content&quot;&gt;<br /> *[[:Category: Coumarin Anticoagulant | Coumarin Anticoagulant]]<br /> *[[:Category: Direct Factor Xa inhibitor | Direct Factor Xa inhibitor]]<br /> *[[:Category: Direct Thrombin Inhibitor | Direct Thrombin Inhibitor]]<br /> &lt;/div&gt;<br /> &lt;/div&gt;<br /> |}<br /> <br /> {|<br /> |&lt;div class=&quot;toccolours mw-collapsible mw-collapsed&quot;&gt;[[:Category:Anticonvulsant | Anticonvulsant]]<br /> &lt;div class=&quot;mw-collapsible-content&quot;&gt;<br /> *[[Carbamazepine]]<br /> *[[Gabapentin]]<br /> *[[Levetiracetam]]<br /> *[[Oxcarbamzepine]]<br /> *[[Phenobarbital]]<br /> *[[Phenytoin]]<br /> *[[Pregabalin]]<br /> *[[Topiramate]]<br /> *[[Valproate]]<br /> *[[Vigabatrin]]<br /> &lt;/div&gt;<br /> &lt;/div&gt;<br /> |}<br /> <br /> {|<br /> |&lt;div class=&quot;toccolours mw-collapsible mw-collapsed&quot;&gt;[[:Category: Antidementia Drug | Antidementia Drug]]<br /> &lt;div class=&quot;mw-collapsible-content&quot;&gt;<br /> *[[:Category: Acetylcholinesterase inhibitor | Acetylcholinesterase Inhibitor]]<br /> *[[:Category: NMDA receptor antagonist | NMDA Receptor Antagonist]]<br /> &lt;/div&gt;<br /> &lt;/div&gt;<br /> |}<br /> <br /> {|<br /> |&lt;div class=&quot;toccolours mw-collapsible mw-collapsed&quot;&gt;[[:Category:Antidepressant Drug | Antidepressants Drug]]<br /> &lt;div class=&quot;mw-collapsible-content&quot;&gt;<br /> *[[:Category: Atypical antidepressants | Atypical Antidepressants]]<br /> *[[:Category: Selective serotonin reuptake inhibitor | Selective Serotonin Reuptake Inhibitors, SSRI]]<br /> *[[:Category: Serotonin-norepinephrine reuptake inhibitor | Serotonin-Norepinephrine Reuptake Inhibitors, SNRIs]]<br /> *[[:Category: Tricyclic antiperessant drug | Tricyclic Antidepressant Drug, TCA]]<br /> &lt;/div&gt;<br /> &lt;/div&gt;<br /> |}<br /> <br /> {|<br /> |&lt;div class=&quot;toccolours mw-collapsible mw-collapsed&quot;&gt;[[:Category:Antidiabetic Drug | Antidiabetic Drug]]<br /> &lt;div class=&quot;mw-collapsible-content&quot;&gt;<br /> *[[:Category: Alpha-glucosidase inhibitors | Alpha-glucosidase inhibitors]]<br /> *[[:Category: Biguanide | Biguanide]]<br /> *[[:Category: Dipeptidyl peptidase-4 (DPP-4) inhibitor | Dipeptidyl peptidase-4 (DPP-4) inhibitor]]<br /> *[[:Category: Sodium-glucose co-transporter 2 (SGLT2) inhibitor | Sodium-glucose co-transporter 2 (SGLT2) inhibitor]]<br /> *[[:Category: Sulfonylureas | Sulfonylureas]]<br /> *[[:Category: Thiazolidinedione | Thiazolidinedione]]<br /> &lt;/div&gt;<br /> &lt;/div&gt;<br /> |}<br /> <br /> {|<br /> |&lt;div class=&quot;toccolours mw-collapsible mw-collapsed&quot;&gt;[[:Category:Antibiotics | Antibiotics]]<br /> &lt;div class=&quot;mw-collapsible-content&quot;&gt;<br /> *[[:Category: Beta-Lactam Antibiotics | β-Lactam Antibiotics]]<br /> *[[:Category: First Generation Cephalosporin Antibiotic | First-Generation Cephalosporin Antibiotic]]<br /> *[[:Category: Second Generation Cephalosporin Antibiotic | Second-Generation Cephalosporin Antibiotic]]<br /> *[[:Category: Third Generation Cephalosporin Antibiotic | Third-Generation Cephalosporin Antibiotic]]<br /> *[[:Category: Carbapenem | Carbapenem]]<br /> *[[:Category: Fluoroquinolone | Fluoroquinolone]]<br /> &lt;/div&gt;<br /> &lt;/div&gt;<br /> |}<br /> <br /> {|<br /> |&lt;div class=&quot;toccolours mw-collapsible mw-collapsed&quot;&gt;[[:Category:Antiparkinsonian Drug | Antiparkinsonian Drug]]<br /> &lt;div class=&quot;mw-collapsible-content&quot;&gt;<br /> *[[:Category: Dopamine D2 receptor agonist | Dopamine D2 Receptor Agonist]]<br /> *[[:Category: Dopaminergic Antiparkinsonian agent | Dopaminergic Antiparkinsonian Agent]]<br /> *[[:Category: Monoamine oxidase B inhibitor | Monoamine Oxidase B Inhibitor, MAO-B Inhibitor]]<br /> &lt;/div&gt;<br /> &lt;/div&gt;<br /> |}<br /> <br /> {|<br /> |&lt;div class=&quot;toccolours mw-collapsible mw-collapsed&quot;&gt;[[:Category:Antipsychotic Drug | Antipsychotic Drug]]<br /> &lt;div class=&quot;mw-collapsible-content&quot;&gt;<br /> *[[:Category: Atypical antipsychotic | Atypical Antipsychotic]]<br /> *[[:Category: Typical Antipsychotic | Typical Antipsychotic]]<br /> &lt;/div&gt;<br /> &lt;/div&gt;<br /> |}<br /> <br /> {|<br /> |&lt;div class=&quot;toccolour mw-collapsible mw-collapsed&quot;&gt;[[:Category: Benzodiazepine | Benzodiazepines, BDZs]]<br /> &lt;div class=&quot;mw-collapsible-content&quot;&gt;<br /> *[[Alprazolam]]<br /> *[[Bromazepam]]<br /> *[[Clobazam]]<br /> *[[Clonazepam]]<br /> *[[Diazepam]]<br /> *[[Lorazepam]]<br /> *[[Midazolam]]<br /> *[[Nitrazepam]]<br /> *[[Triazolam]]<br /> &lt;/div&gt;<br /> &lt;/div&gt;<br /> |}<br /> <br /> {|<br /> |&lt;div class=&quot;toccolours mw-collapsible mw-collapsed&quot;&gt;[[:Category:Cardiovascular Drug | Cardiovascular Drug]]<br /> &lt;div class=&quot;mw-collapsible-content&quot;&gt; <br /> Although very diverse, cardiovascular drugs can be broadly classified according to their pharmacological action. Basic details of the major groups, together with lists of the drugs are described as follow:<br /> *[[:Category: ACE inhibitors | Angiotensin Converting Enzyme Inhibitors, ACEI]]<br /> *[[:Category: Alpha blockers | α-Blockers]]<br /> *[[:Category: Angiotensin II receptor Blockers ARB | Angiotensin II Receptor Blockers, ARB]]<br /> *[[:Category: Antiarrhythmics | Antiarrhythmics]]<br /> *[[:Category: Antiplatelet drugs | Antiplatelet drugs]]<br /> *[[:Category: Beta blockers | β-Blockers]]<br /> *[[:Category: Calcium-channel Blocker, CCB | Calcium Channel Blocker, CCB]]<br /> *[[:Category: Centrally acting antihypertensives | Centrally Acting Antihypertensives]]<br /> *[[:Category: Diuretics | Diuretics]]<br /> *[[:Category: Lipid regulating drugs | Lipid Regulating Drugs]]<br /> *[[:Category: Nitrates | Nitrates]]<br /> *[[:Category: Vasodilators | Vasodilators]]<br /> &lt;/div&gt;<br /> &lt;/div&gt;<br /> |}<br /> <br /> {|<br /> |&lt;div class=&quot;toccolour mw-collapsible mw-collapsed&quot;&gt;[[:Category: Gastrointestinal Drug | Gastrointestinal Drug]]<br /> &lt;div class=&quot;mw-collapsible-content&quot;&gt;<br /> *[[:Category: Antacids | Antacids]]<br /> *[[:Category: H2 receptor antagonist | H&lt;sub&gt;2&lt;/sub&gt; Receptor Antagonist]]<br /> *[[:Category: Proton pump Inhibitors (PPI) | Proton Pump Inhibitor, PPI]]<br /> &lt;/div&gt;<br /> &lt;/div&gt;<br /> |}<br /> <br /> {|<br /> |&lt;div class=&quot;toccolour mw-collapsible mw-collapsed&quot;&gt;[[:Category: Z-hypnotics | Hypnotics, Non-benzodiazepine GABA&lt;sub&gt;A&lt;/sub&gt; agonists]]<br /> &lt;div class=&quot;mw-collapsible-content&quot;&gt;<br /> *[[Zolpidem]]<br /> *[[Zopiclone]]<br /> &lt;/div&gt;<br /> &lt;/div&gt;<br /> |}<br /> <br /> {|<br /> |&lt;div class=&quot;toccolour mw-collapsible mw-collapsed&quot;&gt;[[:Category: PG Analogs and NSAIDs | PG Analogs &amp; NSAIDs]]<br /> &lt;div class=&quot;mw-collapsible-content&quot;&gt;<br /> *[[:Category: COX-2 inhibitor | COX-2 Inhibitors]]<br /> *[[:Category: tNSAID | Traditional NSAID, tNSAIDs]]<br /> *[[:Category: Other NSAID | Other NSAIDs]]<br /> &lt;/div&gt;<br /> &lt;/div&gt;<br /> |}</div>

Calise https://www.sehk-wiki.org/index.php?title=Category:%E8%B3%AA%E5%AD%90%E6%B3%B5%E6%8A%91%E5%88%B6%E5%8A%91_(PPI)&diff=5081 2025-01-06T07:25:30Z

<p>Calise: </p> <hr /> <div>[[Category: 胃腸藥]] <br /> '''質子泵抑制劑 (PPI)''' (English: [[:Category: Proton Pump Inhibitors (PPI) | Proton Pump Inhibitors (PPI)]])</div>

Calise https://www.sehk-wiki.org/index.php?title=Category:Proton_Pump_Inhibitors_(PPI)&diff=5080 2025-01-06T07:25:26Z

<p>Calise: </p> <hr /> <div>[[Category: Gastrointestinal Drug]] <br /> '''Proton Pump Inhibitors (PPI)''' (中文: [[:Category: 質子泵抑制劑 (PPI) | 質子泵抑制劑 (PPI)]])</div>

Calise https://www.sehk-wiki.org/index.php?title=Category:%E8%83%83%E8%85%B8%E8%97%A5&diff=5079 2025-01-06T07:24:08Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]] <br /> '''胃腸藥 (English: [[:Category: Gastrointestinal Drug | Gastrointestinal Drug]])</div>

Calise https://www.sehk-wiki.org/index.php?title=Category:Gastrointestinal_Drug&diff=5078 2025-01-06T07:24:05Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]] <br /> '''Gastrointestinal Drug (中文: [[:Category: 胃腸藥 | 胃腸藥]])</div>

Calise https://www.sehk-wiki.org/index.php?title=Category:%E8%B3%AA%E5%AD%90%E6%B3%B5%E6%8A%91%E5%88%B6%E5%8A%91_(PPI)&diff=5077 2025-01-06T07:23:43Z

<p>Calise: </p> <hr /> <div>[[Category: 胃腸藥]] <br /> '''質子泵抑制劑 (PPI)''' (English: [[:Category: Gastrointestinal Drug | Gastrointestinal Drug]])</div>

Calise https://www.sehk-wiki.org/index.php?title=Category:Proton_Pump_Inhibitors_(PPI)&diff=5076 2025-01-06T07:23:39Z

<p>Calise: </p> <hr /> <div>[[Category: Gastrointestinal Drug]] <br /> '''Proton Pump Inhibitors (PPI)''' (中文: [[:Category: 胃腸藥 | 胃腸藥]])</div>

Calise https://www.sehk-wiki.org/index.php?title=Category:Gastrointestinal_Drug&diff=5075 2025-01-06T07:23:11Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]] <br /> '''Gastrointestinal Drug (中文: [[:Category: 胃腸藥 | 胃腸藥]]])</div>

Calise https://www.sehk-wiki.org/index.php?title=Category:%E8%B3%AA%E5%AD%90%E6%B3%B5%E6%8A%91%E5%88%B6%E5%8A%91_(PPI)&diff=5074 2025-01-06T07:20:42Z

<p>Calise: Created page with &quot;Category: Drugs &#039;&#039;&#039;質子泵抑制劑 (PPI) (English: Gastrointestinal Drug])&quot;</p> <hr /> <div>[[Category: Drugs]] <br /> '''質子泵抑制劑 (PPI) (English: [[:Category: Gastrointestinal Drug | Gastrointestinal Drug]]])</div>

Calise https://www.sehk-wiki.org/index.php?title=Category:%E8%83%83%E8%85%B8%E8%97%A5&diff=5073 2025-01-06T07:20:40Z

<p>Calise: Created page with &quot;Category: Drugs &#039;&#039;&#039;胃腸藥 (English: Gastrointestinal Drug])&quot;</p> <hr /> <div>[[Category: Drugs]] <br /> '''胃腸藥 (English: [[:Category: Gastrointestinal Drug | Gastrointestinal Drug]]])</div>

Calise https://www.sehk-wiki.org/index.php?title=Category:Proton_Pump_Inhibitors_(PPI)&diff=5072 2025-01-06T07:20:38Z

<p>Calise: Created page with &quot;Category: Drugs &#039;&#039;&#039;Proton Pump Inhibitors (PPI) (中文: 胃腸藥])&quot;</p> <hr /> <div>[[Category: Drugs]] <br /> '''Proton Pump Inhibitors (PPI) (中文: [[:Category: 胃腸藥 | 胃腸藥]]])</div>

Calise https://www.sehk-wiki.org/index.php?title=%E6%B3%AE%E6%89%98%E6%8B%89%E5%94%91&diff=5071 2025-01-06T06:50:46Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]][[Category: 質子泵抑制劑 (PPI)]][[:Category: 胃腸藥 | '''胃腸藥''']] <br /> <br /> '''Drug class: [[:Category: 質子泵抑制劑 (PPI) | 質子泵抑制劑 (PPI)]]''' <br /> <br /> '''泮托拉唑''' (English: [[Pantoprazole (PANTOLOC)]]) <br /> <br /> ==藥物類別== <br /> <br /> 質子泵抑制劑 (PPI) <br /> <br /> ==常見劑量== <br /> <br /> *20 毫克延遲釋放口服片 <br /> <br /> *40 毫克延遲釋放口服片 <br /> <br /> *靜脈注射 (IV) 配方 <br /> <br /> ==藥物商品名稱== <br /> <br /> PANTOLOC <br /> <br /> ==藥物用途== <br /> <br /> 治療 胃食道逆流病 (GERD) <br /> <br /> 管理由 GERD 引起的 食道糜爛 <br /> <br /> 預防因使用非類固醇抗炎藥 (NSAIDs) 而導致的胃損傷 <br /> <br /> ==作用機制== <br /> <br /> 通過不可逆地結合到胃壁細胞中的 H+/K+ ATPase 酶，從而有效抑制胃酸生成的最終步驟，導致胃內酸分泌減少。 <br /> <br /> ==給藥途徑== <br /> <br /> 口服 <br /> <br /> 靜脈注射（注射） <br /> <br /> ==劑量== <br /> <br /> GERD: 每日 40 毫克，持續最多 8 周 <br /> <br /> 對於腎功能受損的患者，根據 eGFR 通常不需要特定劑量調整，但建議謹慎使用。 <br /> <br /> ==副作用== <br /> <br /> {| class=&quot;wikitable&quot; <br /> !style=&quot;text-align: left&quot;| 頻率 <br /> !不良反應 <br /> |- <br /> | rowspan=6 | '''常見副作用包括： <br /> |- <br /> | 腹瀉 <br /> |- <br /> | 腹痛 <br /> |- <br /> | 噁心 <br /> |- <br /> | 嘔吐 <br /> |- <br /> | 腹脹 <br /> |- <br /> | rowspan=6 | '''嚴重副作用可能包括： <br /> |- <br /> | 骨質疏鬆相關的骨折 <br /> |- <br /> | 低血鎂水平（低鎂血症） <br /> |- <br /> | 過敏反應 <br /> |- <br /> | 艱難梭菌感染 <br /> |- <br /> | 維生素B12缺乏症 <br /> |} <br /> ==藥物動力學== <br /> <br /> 起效時間：口服後約 2 至 3 小時可觀察到效果。 <br /> <br /> 作用持續時間：酸抑制效果持續約 24 小時。 <br /> <br /> ==用藥注意事項== <br /> <br /> 懷孕：懷孕期間使用應謹慎 <br /> <br /> 哺乳：哺乳期間的安全性尚不明確；請諮詢醫療提供者。 <br /> <br /> 兒童和老年人：對於超過 5 歲的兒童通常是安全的；老年患者可能需要監測，以防止副作用風險增加。 <br /> <br /> 監測項目：定期監測鎂和維生素 B12 水平 <br /> <br /> 藥物相互作用：Pantoprazole 可能與華法林、甲氨蝶呤及某些抗真菌藥物相互作用。它可能影響需要酸性環境吸收的藥物。 <br /> <br /> ==常見問題== <br /> <br /> '''我應該如何服用這種藥片？ <br /> <br /> 在餐前服用 Pantoprazole，整片吞下，不要壓碎或咀嚼。 <br /> <br /> '''服用時應避免什麼？ <br /> <br /> 在未諮詢醫療提供者之前，避免服用其他增加胃酸的藥物。 <br /> <br /> '''如果我錯過一劑怎麼辦？ <br /> <br /> 請儘快服用。如果距離下一劑時間已近，則跳過錯過的劑量，請勿重複服用。</div>

Calise https://www.sehk-wiki.org/index.php?title=%E5%8F%B3%E8%98%AD%E7%B4%A2%E6%8B%89%E5%94%91&diff=5070 2025-01-06T06:50:42Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]][[Category: 質子泵抑制劑 (PPI)]][[:Category: 胃腸藥 | '''胃腸藥''']] <br /> <br /> '''Drug class: [[:Category: 質子泵抑制劑 (PPI) | 質子泵抑制劑 (PPI)]]''' <br /> <br /> '''右蘭索拉唑''' (English: [[Dexlansoprazole (DEXILANT)]]) <br /> <br /> ==藥物類別== <br /> <br /> 質子泵抑制劑 (PPI) <br /> <br /> ==常見劑量== <br /> <br /> *30 毫克延遲釋放膠囊 <br /> <br /> *60 毫克延遲釋放膠囊 <br /> <br /> ==藥物商品名稱== <br /> <br /> DEXILANT <br /> <br /> ==藥物用途== <br /> <br /> 糜爛性食道炎的治愈 (EE) <br /> <br /> 維持已癒合的食道炎 (EE) <br /> <br /> 胃食道逆流的治療 (GERD) <br /> <br /> ==作用機制== <br /> <br /> 通過不可逆地結合到胃壁細胞中的 H+/K+ ATPase 酶，從而有效抑制胃酸生成的最終步驟，導致胃內酸分泌減少。 <br /> <br /> ==給藥途徑== <br /> <br /> 口服 <br /> <br /> ==劑量== <br /> <br /> 對於 12 歲及以上的成年人和兒童，典型劑量為： <br /> <br /> 糜爛性食道炎：每日一次 60 毫克，最多可用 8 週 <br /> <br /> 維持劑量：每日一次30 毫克，持續 6 個月 <br /> <br /> 胃食道逆流的治療: 每日一次 30 毫克，最多可用 4 週 <br /> <br /> 對於腎功能受損的患者，根據 eGFR 通常不需要特定劑量調整，但建議謹慎使用。 <br /> <br /> ==副作用== <br /> <br /> {| class=&quot;wikitable&quot; <br /> !style=&quot;text-align: left&quot;| 頻率 <br /> !不良反應 <br /> |- <br /> | rowspan=6 | '''常見副作用包括： <br /> |- <br /> | 腹瀉 <br /> |- <br /> | 腹痛 <br /> |- <br /> | 噁心 <br /> |- <br /> | 嘔吐 <br /> |- <br /> | 腹脹 <br /> |- <br /> | rowspan=6 | '''嚴重副作用可能包括： <br /> |- <br /> | 骨質疏鬆相關的骨折 <br /> |- <br /> | 低血鎂水平（低鎂血症） <br /> |- <br /> | 過敏反應 <br /> |- <br /> | 艱難梭菌感染 <br /> |- <br /> | 維生素B12缺乏症 <br /> |} <br /> ==藥物動力學== <br /> <br /> 雙釋放機制: <br /> <br /> 起效：1至2小時（第一個高峰），4至5小時（第二個高峰） <br /> <br /> 作用持續時間：長達24小時，比其他質子泵抑制劑更長； <br /> <br /> ==用藥注意事項== <br /> <br /> 懷孕：懷孕期間使用應謹慎 <br /> <br /> 哺乳：哺乳期間的安全性尚不明確；請諮詢醫療提供者。 <br /> <br /> 兒童和老年人：批准用於 12 歲及以上的兒童；老年患者可能需要監測，因為可能對藥物更敏感。 <br /> <br /> 監測項目：定期監測鎂和維生素 B12 水平 <br /> <br /> 藥物相互作用：Dexlansoprazole 可能與由 CYP2C19 和 CYP3A4 酶代謝的藥物相互作用，包括某些抗凝劑和抗癲癇藥物。 <br /> <br /> ==常見問題== <br /> <br /> '''我應該如何服用這種藥片？ <br /> <br /> 無論進食與否均可服用 dexlansoprazole，整顆吞下，不要咀嚼。 <br /> <br /> '''服用時應避免什麼？ <br /> <br /> 在未諮詢醫療提供者之前，避免服用其他增加胃酸的藥物或某些抗生素。 <br /> <br /> '''如果我錯過一劑怎麼辦？ <br /> <br /> 請儘快服用。如果距離下一劑時間已近，則跳過錯過的劑量，請勿重複服用。</div>

Calise https://www.sehk-wiki.org/index.php?title=%E6%B3%AE%E6%89%98%E6%8B%89%E5%94%91&diff=5069 2025-01-06T06:48:37Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]][[Category: 質子泵抑制劑 (PPI)]][[:Category: 胃腸藥 | '''胃腸藥''']] <br /> <br /> '''Drug class: [[:Category: 質子泵抑制劑 (PPI) | 質子泵抑制劑 (PPI)]]''' <br /> <br /> '''泮托拉唑''' (English: [[Pantoprazole]]) <br /> <br /> ==藥物類別== <br /> <br /> 質子泵抑制劑 (PPI) <br /> <br /> ==常見劑量== <br /> <br /> *20 毫克延遲釋放口服片 <br /> <br /> *40 毫克延遲釋放口服片 <br /> <br /> *靜脈注射 (IV) 配方 <br /> <br /> ==藥物商品名稱== <br /> <br /> PANTOLOC <br /> <br /> ==藥物用途== <br /> <br /> 治療 胃食道逆流病 (GERD) <br /> <br /> 管理由 GERD 引起的 食道糜爛 <br /> <br /> 預防因使用非類固醇抗炎藥 (NSAIDs) 而導致的胃損傷 <br /> <br /> ==作用機制== <br /> <br /> 通過不可逆地結合到胃壁細胞中的 H+/K+ ATPase 酶，從而有效抑制胃酸生成的最終步驟，導致胃內酸分泌減少。 <br /> <br /> ==給藥途徑== <br /> <br /> 口服 <br /> <br /> 靜脈注射（注射） <br /> <br /> ==劑量== <br /> <br /> GERD: 每日 40 毫克，持續最多 8 周 <br /> <br /> 對於腎功能受損的患者，根據 eGFR 通常不需要特定劑量調整，但建議謹慎使用。 <br /> <br /> ==副作用== <br /> <br /> {| class=&quot;wikitable&quot; <br /> !style=&quot;text-align: left&quot;| 頻率 <br /> !不良反應 <br /> |- <br /> | rowspan=6 | '''常見副作用包括： <br /> |- <br /> | 腹瀉 <br /> |- <br /> | 腹痛 <br /> |- <br /> | 噁心 <br /> |- <br /> | 嘔吐 <br /> |- <br /> | 腹脹 <br /> |- <br /> | rowspan=6 | '''嚴重副作用可能包括： <br /> |- <br /> | 骨質疏鬆相關的骨折 <br /> |- <br /> | 低血鎂水平（低鎂血症） <br /> |- <br /> | 過敏反應 <br /> |- <br /> | 艱難梭菌感染 <br /> |- <br /> | 維生素B12缺乏症 <br /> |} <br /> ==藥物動力學== <br /> <br /> 起效時間：口服後約 2 至 3 小時可觀察到效果。 <br /> <br /> 作用持續時間：酸抑制效果持續約 24 小時。 <br /> <br /> ==用藥注意事項== <br /> <br /> 懷孕：懷孕期間使用應謹慎 <br /> <br /> 哺乳：哺乳期間的安全性尚不明確；請諮詢醫療提供者。 <br /> <br /> 兒童和老年人：對於超過 5 歲的兒童通常是安全的；老年患者可能需要監測，以防止副作用風險增加。 <br /> <br /> 監測項目：定期監測鎂和維生素 B12 水平 <br /> <br /> 藥物相互作用：Pantoprazole 可能與華法林、甲氨蝶呤及某些抗真菌藥物相互作用。它可能影響需要酸性環境吸收的藥物。 <br /> <br /> ==常見問題== <br /> <br /> '''我應該如何服用這種藥片？ <br /> <br /> 在餐前服用 Pantoprazole，整片吞下，不要壓碎或咀嚼。 <br /> <br /> '''服用時應避免什麼？ <br /> <br /> 在未諮詢醫療提供者之前，避免服用其他增加胃酸的藥物。 <br /> <br /> '''如果我錯過一劑怎麼辦？ <br /> <br /> 請儘快服用。如果距離下一劑時間已近，則跳過錯過的劑量，請勿重複服用。</div>

Calise https://www.sehk-wiki.org/index.php?title=Pantoprazole_(PANTOLOC)&diff=5068 2025-01-06T06:48:36Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]][[Category: Proton Pump Inhibitors (PPI)]][[:Category: Gastrointestinal Drug | '''Gastrointestinal Drug''']] <br /> <br /> '''Drug class: [[:Category: Proton Pump Inhibitors (PPI) | Proton Pump Inhibitors (PPI)]]''' <br /> <br /> '''Pantoprazole''' (中文: [[泮托拉唑]]) <br /> <br /> ==Drug Class== <br /> <br /> Proton Pump Inhibitor (PPI) <br /> <br /> ==Common Strengths of Pantoprazole tablet== <br /> <br /> Pantoprazole tablet are available in the following strengths: <br /> <br /> *20 mg delayed-release oral tablets <br /> <br /> *40 mg delayed-release oral tablets <br /> <br /> *Intravenous (IV) formulation for injection <br /> <br /> ==Drug Trade Name of Pantoprazole tablet== <br /> <br /> PANTOLOC <br /> <br /> ==Drug Usage== <br /> <br /> Pantoprazole is used for: <br /> <br /> Healing of erosive esophagitis (EE) <br /> <br /> Management of erosive esophagitis due to GERD <br /> <br /> Treatment of gastroesophageal reflux disease (GERD) <br /> <br /> Prevention of gastric damage in patients taking NSAIDs <br /> <br /> ==Mechanism of Action== <br /> <br /> Inhibits (H+/K+ )-ATPase enzyme in the gastric parietal cells, blocking gastric acid production in the stomach <br /> <br /> ==Route of Administration== <br /> <br /> Oral and intravenously (injection) <br /> <br /> ==Dosages == <br /> <br /> For adults and children aged 12 years and older, the typical dosage is: <br /> <br /> GERD: 40 mg once daily for up to 8 weeks <br /> <br /> ==Renal Dose Adjustments== <br /> <br /> There are no specific renal dose adjustments recommended based on estimated glomerular filtration rate (eGFR) for pantoprazole; however, caution should be exercised in severe renal impairment. <br /> <br /> ==Side Effects== <br /> <br /> {| class=&quot;wikitable&quot; <br /> !style=&quot;text-align: left&quot;| Frequency <br /> !Adverse reactions <br /> |- <br /> | rowspan=6 | '''Common Side Effects <br /> |- <br /> | Diarrhea <br /> |- <br /> | Abdominal pain <br /> |- <br /> | Nausea <br /> |- <br /> | Vomiting <br /> |- <br /> | Flatulence <br /> |- <br /> | rowspan=5 | '''Serious Side Effects <br /> |- <br /> | Bone fractures <br /> |- <br /> | Clostridium difficile infection <br /> |- <br /> | Anaphylaxis <br /> |- <br /> | Vitamin B12 deficiency <br /> |} <br /> ==Pharmacokinetics== <br /> <br /> Onset Time: Effects can be observed within 2 to 3 hours after oral administration. <br /> <br /> Duration of Action: The acid-suppressive effect lasts approximately 24 hours. <br /> <br /> ==Drug Precautions== <br /> <br /> Pregnancy: Pantoprazole should be used during pregnancy only if clearly needed, as its safety has not been established. <br /> <br /> Breastfeeding: It is not known whether pantoprazole passes into breast milk; caution is advised. <br /> <br /> Children and Elderly: Use in children over 5 years is generally safe; elderly patients may require monitoring due to the potential increased risk of side effects. <br /> <br /> ==Monitoring Items== <br /> <br /> Regular monitoring of magnesium and vitamin B12 levels <br /> <br /> ==Drug Interactions== <br /> <br /> Drug Interactions: Pantoprazole may interact with medications such as warfarin, methotrexate, and certain antifungals. It can affect the absorption of drugs that require an acidic environment. <br /> <br /> ==FAQ== <br /> <br /> '''How should I take the tablet? <br /> <br /> Take pantoprazole before meals, swallowing the tablet whole without crushing or chewing <br /> <br /> '''What should I avoid while taking? <br /> <br /> Avoid highly acidic foods and grapefruit <br /> <br /> '''What happens if I miss a dose? <br /> <br /> Take as soon as remembered unless close to next dose; do not double up on doses</div>

Calise https://www.sehk-wiki.org/index.php?title=%E5%8F%B3%E8%98%AD%E7%B4%A2%E6%8B%89%E5%94%91&diff=5067 2025-01-06T06:48:34Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]][[Category: 質子泵抑制劑 (PPI)]][[:Category: 胃腸藥 | '''胃腸藥''']] <br /> <br /> '''Drug class: [[:Category: 質子泵抑制劑 (PPI) | 質子泵抑制劑 (PPI)]]''' <br /> <br /> '''右蘭索拉唑''' (English: [[Dexlansoprazole]]) <br /> <br /> ==藥物類別== <br /> <br /> 質子泵抑制劑 (PPI) <br /> <br /> ==常見劑量== <br /> <br /> *30 毫克延遲釋放膠囊 <br /> <br /> *60 毫克延遲釋放膠囊 <br /> <br /> ==藥物商品名稱== <br /> <br /> DEXILANT <br /> <br /> ==藥物用途== <br /> <br /> 糜爛性食道炎的治愈 (EE) <br /> <br /> 維持已癒合的食道炎 (EE) <br /> <br /> 胃食道逆流的治療 (GERD) <br /> <br /> ==作用機制== <br /> <br /> 通過不可逆地結合到胃壁細胞中的 H+/K+ ATPase 酶，從而有效抑制胃酸生成的最終步驟，導致胃內酸分泌減少。 <br /> <br /> ==給藥途徑== <br /> <br /> 口服 <br /> <br /> ==劑量== <br /> <br /> 對於 12 歲及以上的成年人和兒童，典型劑量為： <br /> <br /> 糜爛性食道炎：每日一次 60 毫克，最多可用 8 週 <br /> <br /> 維持劑量：每日一次30 毫克，持續 6 個月 <br /> <br /> 胃食道逆流的治療: 每日一次 30 毫克，最多可用 4 週 <br /> <br /> 對於腎功能受損的患者，根據 eGFR 通常不需要特定劑量調整，但建議謹慎使用。 <br /> <br /> ==副作用== <br /> <br /> {| class=&quot;wikitable&quot; <br /> !style=&quot;text-align: left&quot;| 頻率 <br /> !不良反應 <br /> |- <br /> | rowspan=6 | '''常見副作用包括： <br /> |- <br /> | 腹瀉 <br /> |- <br /> | 腹痛 <br /> |- <br /> | 噁心 <br /> |- <br /> | 嘔吐 <br /> |- <br /> | 腹脹 <br /> |- <br /> | rowspan=6 | '''嚴重副作用可能包括： <br /> |- <br /> | 骨質疏鬆相關的骨折 <br /> |- <br /> | 低血鎂水平（低鎂血症） <br /> |- <br /> | 過敏反應 <br /> |- <br /> | 艱難梭菌感染 <br /> |- <br /> | 維生素B12缺乏症 <br /> |} <br /> ==藥物動力學== <br /> <br /> 雙釋放機制: <br /> <br /> 起效：1至2小時（第一個高峰），4至5小時（第二個高峰） <br /> <br /> 作用持續時間：長達24小時，比其他質子泵抑制劑更長； <br /> <br /> ==用藥注意事項== <br /> <br /> 懷孕：懷孕期間使用應謹慎 <br /> <br /> 哺乳：哺乳期間的安全性尚不明確；請諮詢醫療提供者。 <br /> <br /> 兒童和老年人：批准用於 12 歲及以上的兒童；老年患者可能需要監測，因為可能對藥物更敏感。 <br /> <br /> 監測項目：定期監測鎂和維生素 B12 水平 <br /> <br /> 藥物相互作用：Dexlansoprazole 可能與由 CYP2C19 和 CYP3A4 酶代謝的藥物相互作用，包括某些抗凝劑和抗癲癇藥物。 <br /> <br /> ==常見問題== <br /> <br /> '''我應該如何服用這種藥片？ <br /> <br /> 無論進食與否均可服用 dexlansoprazole，整顆吞下，不要咀嚼。 <br /> <br /> '''服用時應避免什麼？ <br /> <br /> 在未諮詢醫療提供者之前，避免服用其他增加胃酸的藥物或某些抗生素。 <br /> <br /> '''如果我錯過一劑怎麼辦？ <br /> <br /> 請儘快服用。如果距離下一劑時間已近，則跳過錯過的劑量，請勿重複服用。</div>

Calise https://www.sehk-wiki.org/index.php?title=Dexlansoprazole_(DEXILANT)&diff=5066 2025-01-06T06:48:33Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]][[Category: Proton Pump Inhibitors (PPI)]][[:Category: Gastrointestinal Drug | '''Gastrointestinal Drug''']] <br /> <br /> '''Drug class: [[:Category: Proton Pump Inhibitors (PPI) | Proton Pump Inhibitors (PPI)]]''' <br /> <br /> '''Dexlansoprazole''' (中文: [[右蘭索拉唑]]) <br /> <br /> ==Drug Class== <br /> <br /> Proton Pump Inhibitors (PPI) <br /> <br /> ==Common Strengths of Dexlansoprazole capsule== <br /> <br /> Dexlansoprazole capsule are available in the following strengths: <br /> <br /> *30 mg delayed-release capsules <br /> <br /> *60mg delayed-release capsules <br /> <br /> ==Drug Trade Names of Dexlansoprazole capsule== <br /> <br /> Dexilant <br /> <br /> ==Drug Usage== <br /> <br /> Dexlansoprazole is used for: <br /> <br /> *Healing of erosive esophagitis (EE) <br /> <br /> *Maintenance of healed erosive esophagitis (EE) <br /> <br /> *Treatment of gastroesophageal reflux disease (GERD) <br /> <br /> ==Mechanism of Action== <br /> <br /> Inhibits (H+/K+ )-ATPase enzyme in the gastric parietal cells, blocking gastric acid production in the stomach <br /> <br /> ==Route of Administration== <br /> <br /> Oral <br /> <br /> ==Dosages == <br /> <br /> For adults and children aged 12 years and older, the typical dosage is: <br /> <br /> Healing: 60 mg once daily for up to 8 weeks <br /> <br /> Maintenance: 30 mg once daily for up to 6 months <br /> <br /> GERD: 30 mg once daily for up to 4 weeks <br /> <br /> ==Renal Dose Adjustments== <br /> <br /> No renal dose adjustment recommended <br /> <br /> ==Side Effects== <br /> <br /> {| class=&quot;wikitable&quot; <br /> !style=&quot;text-align: left&quot;| Frequency <br /> !Adverse reactions <br /> |- <br /> | rowspan=6 | '''Common Side Effects <br /> |- <br /> | Diarrhea <br /> |- <br /> | Abdominal pain <br /> |- <br /> | Nausea <br /> |- <br /> | Vomiting <br /> |- <br /> | Flatulence <br /> |- <br /> | rowspan=6 | '''Serious Side Effects <br /> |- <br /> | Bone fractures <br /> |- <br /> | Low blood magnesium levels <br /> |- <br /> | Clostridium difficile infection <br /> |- <br /> | Anaphylaxis <br /> |- <br /> | Vitamin B12 deficiency <br /> |} <br /> ==Pharmacokinetics== <br /> <br /> Dual-release mechanism <br /> <br /> Onset of action: 1-2 hours (first peak), 4-5 hours (second peak); <br /> <br /> Duration of action: Up to 24 hours, longer than other PPIs <br /> <br /> ==Drug Precautions== <br /> <br /> Pregnancy: Caution advised; Children: Safety not established; Elderly: Monitoring recommended <br /> <br /> Breastfeeding: safety during breastfeeding is unclear <br /> <br /> Children and Elderly: Approved for use in children aged 12 years and older; elderly patients may require monitoring due to potential increased sensitivity. <br /> <br /> ==Monitoring Items== <br /> <br /> Regular monitoring of magnesium and vitamin B12 levels <br /> <br /> ==Drug Interactions== <br /> <br /> Dexlansoprazole can interact with drugs metabolized by CYP2C19 and CYP3A4 enzymes <br /> <br /> Interacts with methotrexate, digoxin, warfarin, certain antiretrovirals <br /> <br /> ==FAQ== <br /> <br /> '''How should I take the tablet? <br /> <br /> Take with or without food; swallow whole or sprinkle on apple sauce/water <br /> <br /> '''What should I avoid while taking? <br /> <br /> Avoid highly acidic foods and grapefruit <br /> <br /> '''What happens if I miss a dose? <br /> <br /> Take as soon as remembered unless close to next dose; do not double up on doses</div>

Calise https://www.sehk-wiki.org/index.php?title=%E6%B3%AE%E6%89%98%E6%8B%89%E5%94%91&diff=5065 2025-01-06T06:48:24Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]][[Category: 質子泵抑制劑 (PPI)]][[:Category: 胃腸藥 | '''胃腸藥''']] <br /> <br /> '''Drug class: [[:Category: 質子泵抑制劑 (PPI) | 質子泵抑制劑 (PPI)]]''' <br /> <br /> '''泮托拉唑''' (English: [[Pantoprazole]]) <br /> <br /> ==藥物類別== <br /> <br /> 質子泵抑制劑 (PPI) edits123<br /> <br /> ==常見劑量== <br /> <br /> *20 毫克延遲釋放口服片 <br /> <br /> *40 毫克延遲釋放口服片 <br /> <br /> *靜脈注射 (IV) 配方 <br /> <br /> ==藥物商品名稱== <br /> <br /> PANTOLOC <br /> <br /> ==藥物用途== <br /> <br /> 治療 胃食道逆流病 (GERD) <br /> <br /> 管理由 GERD 引起的 食道糜爛 <br /> <br /> 預防因使用非類固醇抗炎藥 (NSAIDs) 而導致的胃損傷 <br /> <br /> ==作用機制== <br /> <br /> 通過不可逆地結合到胃壁細胞中的 H+/K+ ATPase 酶，從而有效抑制胃酸生成的最終步驟，導致胃內酸分泌減少。 <br /> <br /> ==給藥途徑== <br /> <br /> 口服 <br /> <br /> 靜脈注射（注射） <br /> <br /> ==劑量== <br /> <br /> GERD: 每日 40 毫克，持續最多 8 周 <br /> <br /> 對於腎功能受損的患者，根據 eGFR 通常不需要特定劑量調整，但建議謹慎使用。 <br /> <br /> ==副作用== <br /> <br /> {| class=&quot;wikitable&quot; <br /> !style=&quot;text-align: left&quot;| 頻率 <br /> !不良反應 <br /> |- <br /> | rowspan=6 | '''常見副作用包括： <br /> |- <br /> | 腹瀉 <br /> |- <br /> | 腹痛 <br /> |- <br /> | 噁心 <br /> |- <br /> | 嘔吐 <br /> |- <br /> | 腹脹 <br /> |- <br /> | rowspan=6 | '''嚴重副作用可能包括： <br /> |- <br /> | 骨質疏鬆相關的骨折 <br /> |- <br /> | 低血鎂水平（低鎂血症） <br /> |- <br /> | 過敏反應 <br /> |- <br /> | 艱難梭菌感染 <br /> |- <br /> | 維生素B12缺乏症 <br /> |} <br /> ==藥物動力學== <br /> <br /> 起效時間：口服後約 2 至 3 小時可觀察到效果。 <br /> <br /> 作用持續時間：酸抑制效果持續約 24 小時。 <br /> <br /> ==用藥注意事項== <br /> <br /> 懷孕：懷孕期間使用應謹慎 <br /> <br /> 哺乳：哺乳期間的安全性尚不明確；請諮詢醫療提供者。 <br /> <br /> 兒童和老年人：對於超過 5 歲的兒童通常是安全的；老年患者可能需要監測，以防止副作用風險增加。 <br /> <br /> 監測項目：定期監測鎂和維生素 B12 水平 <br /> <br /> 藥物相互作用：Pantoprazole 可能與華法林、甲氨蝶呤及某些抗真菌藥物相互作用。它可能影響需要酸性環境吸收的藥物。 <br /> <br /> ==常見問題== <br /> <br /> '''我應該如何服用這種藥片？ <br /> <br /> 在餐前服用 Pantoprazole，整片吞下，不要壓碎或咀嚼。 <br /> <br /> '''服用時應避免什麼？ <br /> <br /> 在未諮詢醫療提供者之前，避免服用其他增加胃酸的藥物。 <br /> <br /> '''如果我錯過一劑怎麼辦？ <br /> <br /> 請儘快服用。如果距離下一劑時間已近，則跳過錯過的劑量，請勿重複服用。</div>

Calise https://www.sehk-wiki.org/index.php?title=Pantoprazole_(PANTOLOC)&diff=5064 2025-01-06T06:48:15Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]][[Category: Proton Pump Inhibitors (PPI)]][[:Category: Gastrointestinal Drug | '''Gastrointestinal Drug''']] <br /> <br /> '''Drug class: [[:Category: Proton Pump Inhibitors (PPI) | Proton Pump Inhibitors (PPI)]]''' <br /> <br /> '''Pantoprazole''' (中文: [[泮托拉唑]]) <br /> <br /> ==Drug Class== <br /> <br /> Proton Pump Inhibitor (PPI) 12345678<br /> <br /> ==Common Strengths of Pantoprazole tablet== <br /> <br /> Pantoprazole tablet are available in the following strengths: <br /> <br /> *20 mg delayed-release oral tablets <br /> <br /> *40 mg delayed-release oral tablets <br /> <br /> *Intravenous (IV) formulation for injection <br /> <br /> ==Drug Trade Name of Pantoprazole tablet== <br /> <br /> PANTOLOC <br /> <br /> ==Drug Usage== <br /> <br /> Pantoprazole is used for: <br /> <br /> Healing of erosive esophagitis (EE) <br /> <br /> Management of erosive esophagitis due to GERD <br /> <br /> Treatment of gastroesophageal reflux disease (GERD) <br /> <br /> Prevention of gastric damage in patients taking NSAIDs <br /> <br /> ==Mechanism of Action== <br /> <br /> Inhibits (H+/K+ )-ATPase enzyme in the gastric parietal cells, blocking gastric acid production in the stomach <br /> <br /> ==Route of Administration== <br /> <br /> Oral and intravenously (injection) <br /> <br /> ==Dosages == <br /> <br /> For adults and children aged 12 years and older, the typical dosage is: <br /> <br /> GERD: 40 mg once daily for up to 8 weeks <br /> <br /> ==Renal Dose Adjustments== <br /> <br /> There are no specific renal dose adjustments recommended based on estimated glomerular filtration rate (eGFR) for pantoprazole; however, caution should be exercised in severe renal impairment. <br /> <br /> ==Side Effects== <br /> <br /> {| class=&quot;wikitable&quot; <br /> !style=&quot;text-align: left&quot;| Frequency <br /> !Adverse reactions <br /> |- <br /> | rowspan=6 | '''Common Side Effects <br /> |- <br /> | Diarrhea <br /> |- <br /> | Abdominal pain <br /> |- <br /> | Nausea <br /> |- <br /> | Vomiting <br /> |- <br /> | Flatulence <br /> |- <br /> | rowspan=5 | '''Serious Side Effects <br /> |- <br /> | Bone fractures <br /> |- <br /> | Clostridium difficile infection <br /> |- <br /> | Anaphylaxis <br /> |- <br /> | Vitamin B12 deficiency <br /> |} <br /> ==Pharmacokinetics== <br /> <br /> Onset Time: Effects can be observed within 2 to 3 hours after oral administration. <br /> <br /> Duration of Action: The acid-suppressive effect lasts approximately 24 hours. <br /> <br /> ==Drug Precautions== <br /> <br /> Pregnancy: Pantoprazole should be used during pregnancy only if clearly needed, as its safety has not been established. <br /> <br /> Breastfeeding: It is not known whether pantoprazole passes into breast milk; caution is advised. <br /> <br /> Children and Elderly: Use in children over 5 years is generally safe; elderly patients may require monitoring due to the potential increased risk of side effects. <br /> <br /> ==Monitoring Items== <br /> <br /> Regular monitoring of magnesium and vitamin B12 levels <br /> <br /> ==Drug Interactions== <br /> <br /> Drug Interactions: Pantoprazole may interact with medications such as warfarin, methotrexate, and certain antifungals. It can affect the absorption of drugs that require an acidic environment. <br /> <br /> ==FAQ== <br /> <br /> '''How should I take the tablet? <br /> <br /> Take pantoprazole before meals, swallowing the tablet whole without crushing or chewing <br /> <br /> '''What should I avoid while taking? <br /> <br /> Avoid highly acidic foods and grapefruit <br /> <br /> '''What happens if I miss a dose? <br /> <br /> Take as soon as remembered unless close to next dose; do not double up on doses</div>

Calise https://www.sehk-wiki.org/index.php?title=%E5%8F%B3%E8%98%AD%E7%B4%A2%E6%8B%89%E5%94%91&diff=5063 2025-01-06T06:48:03Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]][[Category: 質子泵抑制劑 (PPI)]][[:Category: 胃腸藥 | '''胃腸藥''']] <br /> <br /> '''Drug class: [[:Category: 質子泵抑制劑 (PPI) | 質子泵抑制劑 (PPI)]]''' <br /> <br /> '''右蘭索拉唑''' (English: [[Dexlansoprazole]]) <br /> <br /> ==藥物類別== <br /> <br /> 質子泵抑制劑 (PPI) testing 123<br /> <br /> ==常見劑量== <br /> <br /> *30 毫克延遲釋放膠囊 <br /> <br /> *60 毫克延遲釋放膠囊 <br /> <br /> ==藥物商品名稱== <br /> <br /> DEXILANT <br /> <br /> ==藥物用途== <br /> <br /> 糜爛性食道炎的治愈 (EE) <br /> <br /> 維持已癒合的食道炎 (EE) <br /> <br /> 胃食道逆流的治療 (GERD) <br /> <br /> ==作用機制== <br /> <br /> 通過不可逆地結合到胃壁細胞中的 H+/K+ ATPase 酶，從而有效抑制胃酸生成的最終步驟，導致胃內酸分泌減少。 <br /> <br /> ==給藥途徑== <br /> <br /> 口服 <br /> <br /> ==劑量== <br /> <br /> 對於 12 歲及以上的成年人和兒童，典型劑量為： <br /> <br /> 糜爛性食道炎：每日一次 60 毫克，最多可用 8 週 <br /> <br /> 維持劑量：每日一次30 毫克，持續 6 個月 <br /> <br /> 胃食道逆流的治療: 每日一次 30 毫克，最多可用 4 週 <br /> <br /> 對於腎功能受損的患者，根據 eGFR 通常不需要特定劑量調整，但建議謹慎使用。 <br /> <br /> ==副作用== <br /> <br /> {| class=&quot;wikitable&quot; <br /> !style=&quot;text-align: left&quot;| 頻率 <br /> !不良反應 <br /> |- <br /> | rowspan=6 | '''常見副作用包括： <br /> |- <br /> | 腹瀉 <br /> |- <br /> | 腹痛 <br /> |- <br /> | 噁心 <br /> |- <br /> | 嘔吐 <br /> |- <br /> | 腹脹 <br /> |- <br /> | rowspan=6 | '''嚴重副作用可能包括： <br /> |- <br /> | 骨質疏鬆相關的骨折 <br /> |- <br /> | 低血鎂水平（低鎂血症） <br /> |- <br /> | 過敏反應 <br /> |- <br /> | 艱難梭菌感染 <br /> |- <br /> | 維生素B12缺乏症 <br /> |} <br /> ==藥物動力學== <br /> <br /> 雙釋放機制: <br /> <br /> 起效：1至2小時（第一個高峰），4至5小時（第二個高峰） <br /> <br /> 作用持續時間：長達24小時，比其他質子泵抑制劑更長； <br /> <br /> ==用藥注意事項== <br /> <br /> 懷孕：懷孕期間使用應謹慎 <br /> <br /> 哺乳：哺乳期間的安全性尚不明確；請諮詢醫療提供者。 <br /> <br /> 兒童和老年人：批准用於 12 歲及以上的兒童；老年患者可能需要監測，因為可能對藥物更敏感。 <br /> <br /> 監測項目：定期監測鎂和維生素 B12 水平 <br /> <br /> 藥物相互作用：Dexlansoprazole 可能與由 CYP2C19 和 CYP3A4 酶代謝的藥物相互作用，包括某些抗凝劑和抗癲癇藥物。 <br /> <br /> ==常見問題== <br /> <br /> '''我應該如何服用這種藥片？ <br /> <br /> 無論進食與否均可服用 dexlansoprazole，整顆吞下，不要咀嚼。 <br /> <br /> '''服用時應避免什麼？ <br /> <br /> 在未諮詢醫療提供者之前，避免服用其他增加胃酸的藥物或某些抗生素。 <br /> <br /> '''如果我錯過一劑怎麼辦？ <br /> <br /> 請儘快服用。如果距離下一劑時間已近，則跳過錯過的劑量，請勿重複服用。</div>

Calise https://www.sehk-wiki.org/index.php?title=Dexlansoprazole_(DEXILANT)&diff=5062 2025-01-06T06:47:49Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]][[Category: Proton Pump Inhibitors (PPI)]][[:Category: Gastrointestinal Drug | '''Gastrointestinal Drug''']] <br /> <br /> '''Drug class: [[:Category: Proton Pump Inhibitors (PPI) | Proton Pump Inhibitors (PPI)]]''' <br /> <br /> '''Dexlansoprazole''' (中文: [[右蘭索拉唑]]) <br /> <br /> ==Drug Class== <br /> <br /> Proton Pump Inhibitors (PPI) tstig<br /> <br /> ==Common Strengths of Dexlansoprazole capsule== <br /> <br /> Dexlansoprazole capsule are available in the following strengths: <br /> <br /> *30 mg delayed-release capsules <br /> <br /> *60mg delayed-release capsules <br /> <br /> ==Drug Trade Names of Dexlansoprazole capsule== <br /> <br /> Dexilant <br /> <br /> ==Drug Usage== <br /> <br /> Dexlansoprazole is used for: <br /> <br /> *Healing of erosive esophagitis (EE) <br /> <br /> *Maintenance of healed erosive esophagitis (EE) <br /> <br /> *Treatment of gastroesophageal reflux disease (GERD) <br /> <br /> ==Mechanism of Action== <br /> <br /> Inhibits (H+/K+ )-ATPase enzyme in the gastric parietal cells, blocking gastric acid production in the stomach <br /> <br /> ==Route of Administration== <br /> <br /> Oral <br /> <br /> ==Dosages == <br /> <br /> For adults and children aged 12 years and older, the typical dosage is: <br /> <br /> Healing: 60 mg once daily for up to 8 weeks <br /> <br /> Maintenance: 30 mg once daily for up to 6 months <br /> <br /> GERD: 30 mg once daily for up to 4 weeks <br /> <br /> ==Renal Dose Adjustments== <br /> <br /> No renal dose adjustment recommended <br /> <br /> ==Side Effects== <br /> <br /> {| class=&quot;wikitable&quot; <br /> !style=&quot;text-align: left&quot;| Frequency <br /> !Adverse reactions <br /> |- <br /> | rowspan=6 | '''Common Side Effects <br /> |- <br /> | Diarrhea <br /> |- <br /> | Abdominal pain <br /> |- <br /> | Nausea <br /> |- <br /> | Vomiting <br /> |- <br /> | Flatulence <br /> |- <br /> | rowspan=6 | '''Serious Side Effects <br /> |- <br /> | Bone fractures <br /> |- <br /> | Low blood magnesium levels <br /> |- <br /> | Clostridium difficile infection <br /> |- <br /> | Anaphylaxis <br /> |- <br /> | Vitamin B12 deficiency <br /> |} <br /> ==Pharmacokinetics== <br /> <br /> Dual-release mechanism <br /> <br /> Onset of action: 1-2 hours (first peak), 4-5 hours (second peak); <br /> <br /> Duration of action: Up to 24 hours, longer than other PPIs <br /> <br /> ==Drug Precautions== <br /> <br /> Pregnancy: Caution advised; Children: Safety not established; Elderly: Monitoring recommended <br /> <br /> Breastfeeding: safety during breastfeeding is unclear <br /> <br /> Children and Elderly: Approved for use in children aged 12 years and older; elderly patients may require monitoring due to potential increased sensitivity. <br /> <br /> ==Monitoring Items== <br /> <br /> Regular monitoring of magnesium and vitamin B12 levels <br /> <br /> ==Drug Interactions== <br /> <br /> Dexlansoprazole can interact with drugs metabolized by CYP2C19 and CYP3A4 enzymes <br /> <br /> Interacts with methotrexate, digoxin, warfarin, certain antiretrovirals <br /> <br /> ==FAQ== <br /> <br /> '''How should I take the tablet? <br /> <br /> Take with or without food; swallow whole or sprinkle on apple sauce/water <br /> <br /> '''What should I avoid while taking? <br /> <br /> Avoid highly acidic foods and grapefruit <br /> <br /> '''What happens if I miss a dose? <br /> <br /> Take as soon as remembered unless close to next dose; do not double up on doses</div>

Calise https://www.sehk-wiki.org/index.php?title=%E6%B3%AE%E6%89%98%E6%8B%89%E5%94%91&diff=5061 2025-01-06T06:38:47Z

<p>Calise: Created page with &quot;Category: DrugsCategory: 質子泵抑制劑 (PPI) &#039;&#039;&#039;胃腸藥&#039;&#039;&#039; &#039;&#039;&#039;Drug class: 質子泵抑制劑 (PPI)&#039;&#039;&#039; &#039;&#039;&#039;泮托拉唑&#039;&#039;&#039; (English: Pantoprazole) ==藥物類別== 質子泵抑制劑 (PPI) ==常見劑量== *20 毫克延遲釋放口服片 *40 毫克延遲釋放口服片 *靜脈注射 (IV) 配方 ==藥物商品名稱== PANTOLOC ==藥物用途== 治療 胃食道逆...&quot;</p> <hr /> <div>[[Category: Drugs]][[Category: 質子泵抑制劑 (PPI)]][[:Category: 胃腸藥 | '''胃腸藥''']] <br /> <br /> '''Drug class: [[:Category: 質子泵抑制劑 (PPI) | 質子泵抑制劑 (PPI)]]''' <br /> <br /> '''泮托拉唑''' (English: [[Pantoprazole]]) <br /> <br /> ==藥物類別== <br /> <br /> 質子泵抑制劑 (PPI) <br /> <br /> ==常見劑量== <br /> <br /> *20 毫克延遲釋放口服片 <br /> <br /> *40 毫克延遲釋放口服片 <br /> <br /> *靜脈注射 (IV) 配方 <br /> <br /> ==藥物商品名稱== <br /> <br /> PANTOLOC <br /> <br /> ==藥物用途== <br /> <br /> 治療 胃食道逆流病 (GERD) <br /> <br /> 管理由 GERD 引起的 食道糜爛 <br /> <br /> 預防因使用非類固醇抗炎藥 (NSAIDs) 而導致的胃損傷 <br /> <br /> ==作用機制== <br /> <br /> 通過不可逆地結合到胃壁細胞中的 H+/K+ ATPase 酶，從而有效抑制胃酸生成的最終步驟，導致胃內酸分泌減少。 <br /> <br /> ==給藥途徑== <br /> <br /> 口服 <br /> <br /> 靜脈注射（注射） <br /> <br /> ==劑量== <br /> <br /> GERD: 每日 40 毫克，持續最多 8 周 <br /> <br /> 對於腎功能受損的患者，根據 eGFR 通常不需要特定劑量調整，但建議謹慎使用。 <br /> <br /> ==副作用== <br /> <br /> {| class=&quot;wikitable&quot; <br /> !style=&quot;text-align: left&quot;| 頻率 <br /> !不良反應 <br /> |- <br /> | rowspan=6 | '''常見副作用包括： <br /> |- <br /> | 腹瀉 <br /> |- <br /> | 腹痛 <br /> |- <br /> | 噁心 <br /> |- <br /> | 嘔吐 <br /> |- <br /> | 腹脹 <br /> |- <br /> | rowspan=6 | '''嚴重副作用可能包括： <br /> |- <br /> | 骨質疏鬆相關的骨折 <br /> |- <br /> | 低血鎂水平（低鎂血症） <br /> |- <br /> | 過敏反應 <br /> |- <br /> | 艱難梭菌感染 <br /> |- <br /> | 維生素B12缺乏症 <br /> |} <br /> ==藥物動力學== <br /> <br /> 起效時間：口服後約 2 至 3 小時可觀察到效果。 <br /> <br /> 作用持續時間：酸抑制效果持續約 24 小時。 <br /> <br /> ==用藥注意事項== <br /> <br /> 懷孕：懷孕期間使用應謹慎 <br /> <br /> 哺乳：哺乳期間的安全性尚不明確；請諮詢醫療提供者。 <br /> <br /> 兒童和老年人：對於超過 5 歲的兒童通常是安全的；老年患者可能需要監測，以防止副作用風險增加。 <br /> <br /> 監測項目：定期監測鎂和維生素 B12 水平 <br /> <br /> 藥物相互作用：Pantoprazole 可能與華法林、甲氨蝶呤及某些抗真菌藥物相互作用。它可能影響需要酸性環境吸收的藥物。 <br /> <br /> ==常見問題== <br /> <br /> '''我應該如何服用這種藥片？ <br /> <br /> 在餐前服用 Pantoprazole，整片吞下，不要壓碎或咀嚼。 <br /> <br /> '''服用時應避免什麼？ <br /> <br /> 在未諮詢醫療提供者之前，避免服用其他增加胃酸的藥物。 <br /> <br /> '''如果我錯過一劑怎麼辦？ <br /> <br /> 請儘快服用。如果距離下一劑時間已近，則跳過錯過的劑量，請勿重複服用。</div>

Calise https://www.sehk-wiki.org/index.php?title=%E5%8F%B3%E8%98%AD%E7%B4%A2%E6%8B%89%E5%94%91&diff=5060 2025-01-06T06:38:45Z

<p>Calise: Created page with &quot;Category: DrugsCategory: 質子泵抑制劑 (PPI) &#039;&#039;&#039;胃腸藥&#039;&#039;&#039; &#039;&#039;&#039;Drug class: 質子泵抑制劑 (PPI)&#039;&#039;&#039; &#039;&#039;&#039;右蘭索拉唑&#039;&#039;&#039; (English: Dexlansoprazole) ==藥物類別== 質子泵抑制劑 (PPI) ==常見劑量== *30 毫克延遲釋放膠囊 *60 毫克延遲釋放膠囊 ==藥物商品名稱== DEXILANT ==藥物用途== 糜爛性食道炎的治愈 (EE) 維持已癒...&quot;</p> <hr /> <div>[[Category: Drugs]][[Category: 質子泵抑制劑 (PPI)]][[:Category: 胃腸藥 | '''胃腸藥''']] <br /> <br /> '''Drug class: [[:Category: 質子泵抑制劑 (PPI) | 質子泵抑制劑 (PPI)]]''' <br /> <br /> '''右蘭索拉唑''' (English: [[Dexlansoprazole]]) <br /> <br /> ==藥物類別== <br /> <br /> 質子泵抑制劑 (PPI) <br /> <br /> ==常見劑量== <br /> <br /> *30 毫克延遲釋放膠囊 <br /> <br /> *60 毫克延遲釋放膠囊 <br /> <br /> ==藥物商品名稱== <br /> <br /> DEXILANT <br /> <br /> ==藥物用途== <br /> <br /> 糜爛性食道炎的治愈 (EE) <br /> <br /> 維持已癒合的食道炎 (EE) <br /> <br /> 胃食道逆流的治療 (GERD) <br /> <br /> ==作用機制== <br /> <br /> 通過不可逆地結合到胃壁細胞中的 H+/K+ ATPase 酶，從而有效抑制胃酸生成的最終步驟，導致胃內酸分泌減少。 <br /> <br /> ==給藥途徑== <br /> <br /> 口服 <br /> <br /> ==劑量== <br /> <br /> 對於 12 歲及以上的成年人和兒童，典型劑量為： <br /> <br /> 糜爛性食道炎：每日一次 60 毫克，最多可用 8 週 <br /> <br /> 維持劑量：每日一次30 毫克，持續 6 個月 <br /> <br /> 胃食道逆流的治療: 每日一次 30 毫克，最多可用 4 週 <br /> <br /> 對於腎功能受損的患者，根據 eGFR 通常不需要特定劑量調整，但建議謹慎使用。 <br /> <br /> ==副作用== <br /> <br /> {| class=&quot;wikitable&quot; <br /> !style=&quot;text-align: left&quot;| 頻率 <br /> !不良反應 <br /> |- <br /> | rowspan=6 | '''常見副作用包括： <br /> |- <br /> | 腹瀉 <br /> |- <br /> | 腹痛 <br /> |- <br /> | 噁心 <br /> |- <br /> | 嘔吐 <br /> |- <br /> | 腹脹 <br /> |- <br /> | rowspan=6 | '''嚴重副作用可能包括： <br /> |- <br /> | 骨質疏鬆相關的骨折 <br /> |- <br /> | 低血鎂水平（低鎂血症） <br /> |- <br /> | 過敏反應 <br /> |- <br /> | 艱難梭菌感染 <br /> |- <br /> | 維生素B12缺乏症 <br /> |} <br /> ==藥物動力學== <br /> <br /> 雙釋放機制: <br /> <br /> 起效：1至2小時（第一個高峰），4至5小時（第二個高峰） <br /> <br /> 作用持續時間：長達24小時，比其他質子泵抑制劑更長； <br /> <br /> ==用藥注意事項== <br /> <br /> 懷孕：懷孕期間使用應謹慎 <br /> <br /> 哺乳：哺乳期間的安全性尚不明確；請諮詢醫療提供者。 <br /> <br /> 兒童和老年人：批准用於 12 歲及以上的兒童；老年患者可能需要監測，因為可能對藥物更敏感。 <br /> <br /> 監測項目：定期監測鎂和維生素 B12 水平 <br /> <br /> 藥物相互作用：Dexlansoprazole 可能與由 CYP2C19 和 CYP3A4 酶代謝的藥物相互作用，包括某些抗凝劑和抗癲癇藥物。 <br /> <br /> ==常見問題== <br /> <br /> '''我應該如何服用這種藥片？ <br /> <br /> 無論進食與否均可服用 dexlansoprazole，整顆吞下，不要咀嚼。 <br /> <br /> '''服用時應避免什麼？ <br /> <br /> 在未諮詢醫療提供者之前，避免服用其他增加胃酸的藥物或某些抗生素。 <br /> <br /> '''如果我錯過一劑怎麼辦？ <br /> <br /> 請儘快服用。如果距離下一劑時間已近，則跳過錯過的劑量，請勿重複服用。</div>

Calise https://www.sehk-wiki.org/index.php?title=Dexlansoprazole_(DEXILANT)&diff=5059 2025-01-06T06:36:08Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]][[Category: Proton Pump Inhibitors (PPI)]][[:Category: Gastrointestinal Drug | '''Gastrointestinal Drug''']] <br /> <br /> '''Drug class: [[:Category: Proton Pump Inhibitors (PPI) | Proton Pump Inhibitors (PPI)]]''' <br /> <br /> '''Dexlansoprazole''' (中文: [[右蘭索拉唑]]) <br /> <br /> ==Drug Class== <br /> <br /> Proton Pump Inhibitors (PPI) <br /> <br /> ==Common Strengths of Dexlansoprazole capsule== <br /> <br /> Dexlansoprazole capsule are available in the following strengths: <br /> <br /> *30 mg delayed-release capsules <br /> <br /> *60mg delayed-release capsules <br /> <br /> ==Drug Trade Names of Dexlansoprazole capsule== <br /> <br /> Dexilant <br /> <br /> ==Drug Usage== <br /> <br /> Dexlansoprazole is used for: <br /> <br /> *Healing of erosive esophagitis (EE) <br /> <br /> *Maintenance of healed erosive esophagitis (EE) <br /> <br /> *Treatment of gastroesophageal reflux disease (GERD) <br /> <br /> ==Mechanism of Action== <br /> <br /> Inhibits (H+/K+ )-ATPase enzyme in the gastric parietal cells, blocking gastric acid production in the stomach <br /> <br /> ==Route of Administration== <br /> <br /> Oral <br /> <br /> ==Dosages == <br /> <br /> For adults and children aged 12 years and older, the typical dosage is: <br /> <br /> Healing: 60 mg once daily for up to 8 weeks <br /> <br /> Maintenance: 30 mg once daily for up to 6 months <br /> <br /> GERD: 30 mg once daily for up to 4 weeks <br /> <br /> ==Renal Dose Adjustments== <br /> <br /> No renal dose adjustment recommended <br /> <br /> ==Side Effects== <br /> <br /> {| class=&quot;wikitable&quot; <br /> !style=&quot;text-align: left&quot;| Frequency <br /> !Adverse reactions <br /> |- <br /> | rowspan=6 | '''Common Side Effects <br /> |- <br /> | Diarrhea <br /> |- <br /> | Abdominal pain <br /> |- <br /> | Nausea <br /> |- <br /> | Vomiting <br /> |- <br /> | Flatulence <br /> |- <br /> | rowspan=6 | '''Serious Side Effects <br /> |- <br /> | Bone fractures <br /> |- <br /> | Low blood magnesium levels <br /> |- <br /> | Clostridium difficile infection <br /> |- <br /> | Anaphylaxis <br /> |- <br /> | Vitamin B12 deficiency <br /> |} <br /> ==Pharmacokinetics== <br /> <br /> Dual-release mechanism <br /> <br /> Onset of action: 1-2 hours (first peak), 4-5 hours (second peak); <br /> <br /> Duration of action: Up to 24 hours, longer than other PPIs <br /> <br /> ==Drug Precautions== <br /> <br /> Pregnancy: Caution advised; Children: Safety not established; Elderly: Monitoring recommended <br /> <br /> Breastfeeding: safety during breastfeeding is unclear <br /> <br /> Children and Elderly: Approved for use in children aged 12 years and older; elderly patients may require monitoring due to potential increased sensitivity. <br /> <br /> ==Monitoring Items== <br /> <br /> Regular monitoring of magnesium and vitamin B12 levels <br /> <br /> ==Drug Interactions== <br /> <br /> Dexlansoprazole can interact with drugs metabolized by CYP2C19 and CYP3A4 enzymes <br /> <br /> Interacts with methotrexate, digoxin, warfarin, certain antiretrovirals <br /> <br /> ==FAQ== <br /> <br /> '''How should I take the tablet? <br /> <br /> Take with or without food; swallow whole or sprinkle on apple sauce/water <br /> <br /> '''What should I avoid while taking? <br /> <br /> Avoid highly acidic foods and grapefruit <br /> <br /> '''What happens if I miss a dose? <br /> <br /> Take as soon as remembered unless close to next dose; do not double up on doses</div>

Calise https://www.sehk-wiki.org/index.php?title=Dexlansoprazole_(DEXILANT)&diff=5058 2025-01-06T06:35:28Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]][[Category: Proton Pump Inhibitors (PPI)]][[:Category: Gastrointestinal Drug | '''Gastrointestinal Drug''']] <br /> <br /> '''Drug class: [[:Category: Proton Pump Inhibitors (PPI) | Proton Pump Inhibitors (PPI)]]''' <br /> <br /> '''Dexlansoprazole''' (中文: [[右蘭索拉唑]]) <br /> <br /> ==Drug Class== <br /> <br /> Proton Pump Inhibitors (PPI) <br /> <br /> ==Common Strengths of Dexlansoprazole capsule== <br /> <br /> Dexlansoprazole capsule are available in the following strengths: <br /> <br /> *30 mg delayed-release capsules <br /> <br /> *60mg delayed-release capsules <br /> <br /> ==Drug Trade Names of Dexlansoprazole capsule== <br /> <br /> Dexilant : random extra content<br /> <br /> ==Drug Usage== <br /> <br /> Dexlansoprazole is used for: <br /> <br /> *Healing of erosive esophagitis (EE) <br /> <br /> *Maintenance of healed erosive esophagitis (EE) <br /> <br /> *Treatment of gastroesophageal reflux disease (GERD) <br /> <br /> ==Mechanism of Action== <br /> <br /> Inhibits (H+/K+ )-ATPase enzyme in the gastric parietal cells, blocking gastric acid production in the stomach <br /> <br /> ==Route of Administration== <br /> <br /> Oral <br /> <br /> ==Dosages == <br /> <br /> For adults and children aged 12 years and older, the typical dosage is: <br /> <br /> Healing: 60 mg once daily for up to 8 weeks <br /> <br /> Maintenance: 30 mg once daily for up to 6 months <br /> <br /> GERD: 30 mg once daily for up to 4 weeks <br /> <br /> ==Renal Dose Adjustments== <br /> <br /> No renal dose adjustment recommended <br /> <br /> ==Side Effects== <br /> <br /> {| class=&quot;wikitable&quot; <br /> !style=&quot;text-align: left&quot;| Frequency <br /> !Adverse reactions <br /> |- <br /> | rowspan=6 | '''Common Side Effects <br /> |- <br /> | Diarrhea <br /> |- <br /> | Abdominal pain <br /> |- <br /> | Nausea <br /> |- <br /> | Vomiting <br /> |- <br /> | Flatulence <br /> |- <br /> | rowspan=6 | '''Serious Side Effects <br /> |- <br /> | Bone fractures <br /> |- <br /> | Low blood magnesium levels <br /> |- <br /> | Clostridium difficile infection <br /> |- <br /> | Anaphylaxis <br /> |- <br /> | Vitamin B12 deficiency <br /> |} <br /> ==Pharmacokinetics== <br /> <br /> Dual-release mechanism <br /> <br /> Onset of action: 1-2 hours (first peak), 4-5 hours (second peak); <br /> <br /> Duration of action: Up to 24 hours, longer than other PPIs <br /> <br /> ==Drug Precautions== <br /> <br /> Pregnancy: Caution advised; Children: Safety not established; Elderly: Monitoring recommended <br /> <br /> Breastfeeding: safety during breastfeeding is unclear <br /> <br /> Children and Elderly: Approved for use in children aged 12 years and older; elderly patients may require monitoring due to potential increased sensitivity. <br /> <br /> ==Monitoring Items== <br /> <br /> Regular monitoring of magnesium and vitamin B12 levels <br /> <br /> ==Drug Interactions== <br /> <br /> Dexlansoprazole can interact with drugs metabolized by CYP2C19 and CYP3A4 enzymes <br /> <br /> Interacts with methotrexate, digoxin, warfarin, certain antiretrovirals <br /> <br /> ==FAQ== <br /> <br /> '''How should I take the tablet? <br /> <br /> Take with or without food; swallow whole or sprinkle on apple sauce/water <br /> <br /> '''What should I avoid while taking? <br /> <br /> Avoid highly acidic foods and grapefruit <br /> <br /> '''What happens if I miss a dose? <br /> <br /> Take as soon as remembered unless close to next dose; do not double up on doses</div>

Calise https://www.sehk-wiki.org/index.php?title=Pantoprazole_(PANTOLOC)&diff=5057 2025-01-06T06:34:17Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]][[Category: Proton Pump Inhibitors (PPI)]][[:Category: Gastrointestinal Drug | '''Gastrointestinal Drug''']] <br /> <br /> '''Drug class: [[:Category: Proton Pump Inhibitors (PPI) | Proton Pump Inhibitors (PPI)]]''' <br /> <br /> '''Pantoprazole''' (中文: [[泮托拉唑]]) <br /> <br /> ==Drug Class== <br /> <br /> Proton Pump Inhibitor (PPI) <br /> <br /> ==Common Strengths of Pantoprazole tablet== <br /> <br /> Pantoprazole tablet are available in the following strengths: <br /> <br /> *20 mg delayed-release oral tablets <br /> <br /> *40 mg delayed-release oral tablets <br /> <br /> *Intravenous (IV) formulation for injection <br /> <br /> ==Drug Trade Name of Pantoprazole tablet== <br /> <br /> PANTOLOC <br /> <br /> ==Drug Usage== <br /> <br /> Pantoprazole is used for: <br /> <br /> Healing of erosive esophagitis (EE) <br /> <br /> Management of erosive esophagitis due to GERD <br /> <br /> Treatment of gastroesophageal reflux disease (GERD) <br /> <br /> Prevention of gastric damage in patients taking NSAIDs <br /> <br /> ==Mechanism of Action== <br /> <br /> Inhibits (H+/K+ )-ATPase enzyme in the gastric parietal cells, blocking gastric acid production in the stomach <br /> <br /> ==Route of Administration== <br /> <br /> Oral and intravenously (injection) <br /> <br /> ==Dosages == <br /> <br /> For adults and children aged 12 years and older, the typical dosage is: <br /> <br /> GERD: 40 mg once daily for up to 8 weeks <br /> <br /> ==Renal Dose Adjustments== <br /> <br /> There are no specific renal dose adjustments recommended based on estimated glomerular filtration rate (eGFR) for pantoprazole; however, caution should be exercised in severe renal impairment. <br /> <br /> ==Side Effects== <br /> <br /> {| class=&quot;wikitable&quot; <br /> !style=&quot;text-align: left&quot;| Frequency <br /> !Adverse reactions <br /> |- <br /> | rowspan=6 | '''Common Side Effects <br /> |- <br /> | Diarrhea <br /> |- <br /> | Abdominal pain <br /> |- <br /> | Nausea <br /> |- <br /> | Vomiting <br /> |- <br /> | Flatulence <br /> |- <br /> | rowspan=5 | '''Serious Side Effects <br /> |- <br /> | Bone fractures <br /> |- <br /> | Clostridium difficile infection <br /> |- <br /> | Anaphylaxis <br /> |- <br /> | Vitamin B12 deficiency <br /> |} <br /> ==Pharmacokinetics== <br /> <br /> Onset Time: Effects can be observed within 2 to 3 hours after oral administration. <br /> <br /> Duration of Action: The acid-suppressive effect lasts approximately 24 hours. <br /> <br /> ==Drug Precautions== <br /> <br /> Pregnancy: Pantoprazole should be used during pregnancy only if clearly needed, as its safety has not been established. <br /> <br /> Breastfeeding: It is not known whether pantoprazole passes into breast milk; caution is advised. <br /> <br /> Children and Elderly: Use in children over 5 years is generally safe; elderly patients may require monitoring due to the potential increased risk of side effects. <br /> <br /> ==Monitoring Items== <br /> <br /> Regular monitoring of magnesium and vitamin B12 levels <br /> <br /> ==Drug Interactions== <br /> <br /> Drug Interactions: Pantoprazole may interact with medications such as warfarin, methotrexate, and certain antifungals. It can affect the absorption of drugs that require an acidic environment. <br /> <br /> ==FAQ== <br /> <br /> '''How should I take the tablet? <br /> <br /> Take pantoprazole before meals, swallowing the tablet whole without crushing or chewing <br /> <br /> '''What should I avoid while taking? <br /> <br /> Avoid highly acidic foods and grapefruit <br /> <br /> '''What happens if I miss a dose? <br /> <br /> Take as soon as remembered unless close to next dose; do not double up on doses</div>

Calise https://www.sehk-wiki.org/index.php?title=Dexlansoprazole_(DEXILANT)&diff=5056 2025-01-06T06:34:16Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]][[Category: Proton Pump Inhibitors (PPI)]][[:Category: Gastrointestinal Drug | '''Gastrointestinal Drug''']] <br /> <br /> '''Drug class: [[:Category: Proton Pump Inhibitors (PPI) | Proton Pump Inhibitors (PPI)]]''' <br /> <br /> '''Dexlansoprazole''' (中文: [[右蘭索拉唑]]) <br /> <br /> ==Drug Class== <br /> <br /> Proton Pump Inhibitors (PPI) <br /> <br /> ==Common Strengths of Dexlansoprazole capsule== <br /> <br /> Dexlansoprazole capsule are available in the following strengths: <br /> <br /> *30 mg delayed-release capsules <br /> <br /> *60mg delayed-release capsules <br /> <br /> ==Drug Trade Names of Dexlansoprazole capsule== <br /> <br /> Dexilant <br /> <br /> ==Drug Usage== <br /> <br /> Dexlansoprazole is used for: <br /> <br /> *Healing of erosive esophagitis (EE) <br /> <br /> *Maintenance of healed erosive esophagitis (EE) <br /> <br /> *Treatment of gastroesophageal reflux disease (GERD) <br /> <br /> ==Mechanism of Action== <br /> <br /> Inhibits (H+/K+ )-ATPase enzyme in the gastric parietal cells, blocking gastric acid production in the stomach <br /> <br /> ==Route of Administration== <br /> <br /> Oral <br /> <br /> ==Dosages == <br /> <br /> For adults and children aged 12 years and older, the typical dosage is: <br /> <br /> Healing: 60 mg once daily for up to 8 weeks <br /> <br /> Maintenance: 30 mg once daily for up to 6 months <br /> <br /> GERD: 30 mg once daily for up to 4 weeks <br /> <br /> ==Renal Dose Adjustments== <br /> <br /> No renal dose adjustment recommended <br /> <br /> ==Side Effects== <br /> <br /> {| class=&quot;wikitable&quot; <br /> !style=&quot;text-align: left&quot;| Frequency <br /> !Adverse reactions <br /> |- <br /> | rowspan=6 | '''Common Side Effects <br /> |- <br /> | Diarrhea <br /> |- <br /> | Abdominal pain <br /> |- <br /> | Nausea <br /> |- <br /> | Vomiting <br /> |- <br /> | Flatulence <br /> |- <br /> | rowspan=6 | '''Serious Side Effects <br /> |- <br /> | Bone fractures <br /> |- <br /> | Low blood magnesium levels <br /> |- <br /> | Clostridium difficile infection <br /> |- <br /> | Anaphylaxis <br /> |- <br /> | Vitamin B12 deficiency <br /> |} <br /> ==Pharmacokinetics== <br /> <br /> Dual-release mechanism <br /> <br /> Onset of action: 1-2 hours (first peak), 4-5 hours (second peak); <br /> <br /> Duration of action: Up to 24 hours, longer than other PPIs <br /> <br /> ==Drug Precautions== <br /> <br /> Pregnancy: Caution advised; Children: Safety not established; Elderly: Monitoring recommended <br /> <br /> Breastfeeding: safety during breastfeeding is unclear <br /> <br /> Children and Elderly: Approved for use in children aged 12 years and older; elderly patients may require monitoring due to potential increased sensitivity. <br /> <br /> ==Monitoring Items== <br /> <br /> Regular monitoring of magnesium and vitamin B12 levels <br /> <br /> ==Drug Interactions== <br /> <br /> Dexlansoprazole can interact with drugs metabolized by CYP2C19 and CYP3A4 enzymes <br /> <br /> Interacts with methotrexate, digoxin, warfarin, certain antiretrovirals <br /> <br /> ==FAQ== <br /> <br /> '''How should I take the tablet? <br /> <br /> Take with or without food; swallow whole or sprinkle on apple sauce/water <br /> <br /> '''What should I avoid while taking? <br /> <br /> Avoid highly acidic foods and grapefruit <br /> <br /> '''What happens if I miss a dose? <br /> <br /> Take as soon as remembered unless close to next dose; do not double up on doses</div>

Calise https://www.sehk-wiki.org/index.php?title=Pantoprazole_(PANTOLOC)&diff=5055 2025-01-06T06:26:01Z

<p>Calise: Created page with &quot;Category: DrugsCategory: Proton Pump Inhibitors (PPI) &#039;&#039;&#039;Gastrointestinal Drug&#039;&#039;&#039; &#039;&#039;&#039;Drug class: Proton Pump Inhibitors (PPI)&#039;&#039;&#039; &#039;&#039;&#039;Pantoprazole&#039;&#039;&#039; (中文: 泮托拉唑) ==Drug Class== Proton Pump Inhibitor (PPI)&quot;</p> <hr /> <div>[[Category: Drugs]][[Category: Proton Pump Inhibitors (PPI)]][[:Category: Gastrointestinal Drug | '''Gastrointestinal Drug''']] <br /> <br /> '''Drug class: [[:Category: Proton Pump Inhibitors (PPI) | Proton Pump Inhibitors (PPI)]]''' <br /> <br /> '''Pantoprazole''' (中文: [[泮托拉唑]]) <br /> <br /> ==Drug Class== <br /> <br /> Proton Pump Inhibitor (PPI)</div>

Calise https://www.sehk-wiki.org/index.php?title=Dexlansoprazole_(DEXILANT)&diff=5054 2025-01-06T06:26:00Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]][[Category: Proton Pump Inhibitors (PPI)]][[:Category: Gastrointestinal Drug | '''Gastrointestinal Drug''']] <br /> <br /> '''Drug class: [[:Category: Proton Pump Inhibitors (PPI) | Proton Pump Inhibitors (PPI)]]''' <br /> <br /> '''Dexlansoprazole''' (中文: [[右蘭索拉唑]]) <br /> <br /> ==Drug Class== <br /> <br /> Proton Pump Inhibitors (PPI)</div>

Calise https://www.sehk-wiki.org/index.php?title=Dexlansoprazole_(DEXILANT)&diff=5053 2025-01-06T06:24:30Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]][[Category: Proton Pump Inhibitors (PPI)]][[:Category: Gastrointestinal Drug | '''Gastrointestinal Drug''']] <br /> <br /> '''Drug class: [[:Category: Proton Pump Inhibitors (PPI) | Proton Pump Inhibitors (PPI)]]''' <br /> <br /> '''Dexlansoprazole''' (中文: [[右蘭索拉唑]]) <br /> <br /> ==Drug Class== <br /> <br /> Proton Pump Inhibitors (PPI) <br /> <br /> ==Common Strengths of Dexlansoprazole capsule== <br /> <br /> Dexlansoprazole capsule are available in the following strengths: <br /> <br /> *30 mg delayed-release capsules <br /> <br /> *60mg delayed-release capsules <br /> <br /> ==Drug Trade Names of Dexlansoprazole capsule== <br /> <br /> Dexilant</div>

Calise https://www.sehk-wiki.org/index.php?title=Dexlansoprazole_(DEXILANT)&diff=5052 2025-01-06T06:24:28Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]][[Category: Proton Pump Inhibitors (PPI)]][[:Category: Gastrointestinal Drug | '''Gastrointestinal Drug''']] <br /> <br /> '''Drug class: [[:Category: Proton Pump Inhibitors (PPI) | Proton Pump Inhibitors (PPI)]]''' <br /> <br /> '''Dexlansoprazole''' (中文: [[右蘭索拉唑]]) <br /> <br /> ==Drug Class== <br /> <br /> Proton Pump Inhibitors (PPI) <br /> <br /> ==Common Strengths of Dexlansoprazole capsule== <br /> <br /> Dexlansoprazole capsule are available in the following strengths: <br /> <br /> *30 mg delayed-release capsules <br /> <br /> *60mg delayed-release capsules</div>

Calise https://www.sehk-wiki.org/index.php?title=Dexlansoprazole_(DEXILANT)&diff=5051 2025-01-06T06:24:26Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]][[Category: Proton Pump Inhibitors (PPI)]][[:Category: Gastrointestinal Drug | '''Gastrointestinal Drug''']] <br /> <br /> '''Drug class: [[:Category: Proton Pump Inhibitors (PPI) | Proton Pump Inhibitors (PPI)]]''' <br /> <br /> '''Dexlansoprazole''' (中文: [[右蘭索拉唑]]) <br /> <br /> ==Drug Class== <br /> <br /> Proton Pump Inhibitors (PPI) <br /> <br /> ==Common Strengths of Dexlansoprazole capsule== <br /> <br /> Dexlansoprazole capsule are available in the following strengths: <br /> <br /> *30 mg delayed-release capsules</div>

Calise https://www.sehk-wiki.org/index.php?title=Dexlansoprazole_(DEXILANT)&diff=5050 2025-01-06T06:24:25Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]][[Category: Proton Pump Inhibitors (PPI)]][[:Category: Gastrointestinal Drug | '''Gastrointestinal Drug''']] <br /> <br /> '''Drug class: [[:Category: Proton Pump Inhibitors (PPI) | Proton Pump Inhibitors (PPI)]]''' <br /> <br /> '''Dexlansoprazole''' (中文: [[右蘭索拉唑]]) <br /> <br /> ==Drug Class== <br /> <br /> Proton Pump Inhibitors (PPI)</div>

Calise https://www.sehk-wiki.org/index.php?title=Dexlansoprazole_(DEXILANT)&diff=5049 2025-01-06T06:22:54Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]][[Category: Proton Pump Inhibitors (PPI)]][[:Category: Gastrointestinal Drug | '''Gastrointestinal Drug''']] <br /> <br /> '''Drug class: [[:Category: Proton Pump Inhibitors (PPI) | Proton Pump Inhibitors (PPI)]]''' <br /> <br /> '''Dexlansoprazole''' (中文: [[右蘭索拉唑]]) <br /> <br /> ==Drug Class== <br /> <br /> Proton Pump Inhibitors (PPI) <br /> <br /> ==Common Strengths of Dexlansoprazole capsule== <br /> <br /> Dexlansoprazole capsule are available in the following strengths: <br /> <br /> *30 mg delayed-release capsules <br /> <br /> *60mg delayed-release capsules <br /> <br /> ==Drug Trade Names of Dexlansoprazole capsule== <br /> <br /> Dexilant <br /> <br /> ==Drug Usage== <br /> <br /> Dexlansoprazole is used for: <br /> <br /> *Healing of erosive esophagitis (EE) <br /> <br /> *Maintenance of healed erosive esophagitis (EE) <br /> <br /> *Treatment of gastroesophageal reflux disease (GERD) <br /> <br /> ==Mechanism of Action== <br /> <br /> Inhibits (H+/K+ )-ATPase enzyme in the gastric parietal cells, blocking gastric acid production in the stomach <br /> <br /> ==Route of Administration== <br /> <br /> Oral <br /> <br /> ==Dosages == <br /> <br /> For adults and children aged 12 years and older, the typical dosage is: <br /> <br /> Healing: 60 mg once daily for up to 8 weeks <br /> <br /> Maintenance: 30 mg once daily for up to 6 months <br /> <br /> GERD: 30 mg once daily for up to 4 weeks <br /> <br /> ==Renal Dose Adjustments== <br /> <br /> No renal dose adjustment recommended <br /> <br /> ==Side Effects==</div>

Calise https://www.sehk-wiki.org/index.php?title=Dexlansoprazole_(DEXILANT)&diff=5048 2025-01-06T06:22:52Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]][[Category: Proton Pump Inhibitors (PPI)]][[:Category: Gastrointestinal Drug | '''Gastrointestinal Drug''']] <br /> <br /> '''Drug class: [[:Category: Proton Pump Inhibitors (PPI) | Proton Pump Inhibitors (PPI)]]''' <br /> <br /> '''Dexlansoprazole''' (中文: [[右蘭索拉唑]]) <br /> <br /> ==Drug Class== <br /> <br /> Proton Pump Inhibitors (PPI) <br /> <br /> ==Common Strengths of Dexlansoprazole capsule== <br /> <br /> Dexlansoprazole capsule are available in the following strengths: <br /> <br /> *30 mg delayed-release capsules <br /> <br /> *60mg delayed-release capsules <br /> <br /> ==Drug Trade Names of Dexlansoprazole capsule== <br /> <br /> Dexilant <br /> <br /> ==Drug Usage== <br /> <br /> Dexlansoprazole is used for: <br /> <br /> *Healing of erosive esophagitis (EE) <br /> <br /> *Maintenance of healed erosive esophagitis (EE) <br /> <br /> *Treatment of gastroesophageal reflux disease (GERD) <br /> <br /> ==Mechanism of Action== <br /> <br /> Inhibits (H+/K+ )-ATPase enzyme in the gastric parietal cells, blocking gastric acid production in the stomach <br /> <br /> ==Route of Administration== <br /> <br /> Oral <br /> <br /> ==Dosages == <br /> <br /> For adults and children aged 12 years and older, the typical dosage is: <br /> <br /> Healing: 60 mg once daily for up to 8 weeks <br /> <br /> Maintenance: 30 mg once daily for up to 6 months <br /> <br /> GERD: 30 mg once daily for up to 4 weeks <br /> <br /> ==Renal Dose Adjustments== <br /> <br /> No renal dose adjustment recommended</div>

Calise https://www.sehk-wiki.org/index.php?title=Dexlansoprazole_(DEXILANT)&diff=5047 2025-01-06T06:22:51Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]][[Category: Proton Pump Inhibitors (PPI)]][[:Category: Gastrointestinal Drug | '''Gastrointestinal Drug''']] <br /> <br /> '''Drug class: [[:Category: Proton Pump Inhibitors (PPI) | Proton Pump Inhibitors (PPI)]]''' <br /> <br /> '''Dexlansoprazole''' (中文: [[右蘭索拉唑]]) <br /> <br /> ==Drug Class== <br /> <br /> Proton Pump Inhibitors (PPI) <br /> <br /> ==Common Strengths of Dexlansoprazole capsule== <br /> <br /> Dexlansoprazole capsule are available in the following strengths: <br /> <br /> *30 mg delayed-release capsules <br /> <br /> *60mg delayed-release capsules <br /> <br /> ==Drug Trade Names of Dexlansoprazole capsule== <br /> <br /> Dexilant <br /> <br /> ==Drug Usage== <br /> <br /> Dexlansoprazole is used for: <br /> <br /> *Healing of erosive esophagitis (EE) <br /> <br /> *Maintenance of healed erosive esophagitis (EE) <br /> <br /> *Treatment of gastroesophageal reflux disease (GERD) <br /> <br /> ==Mechanism of Action== <br /> <br /> Inhibits (H+/K+ )-ATPase enzyme in the gastric parietal cells, blocking gastric acid production in the stomach <br /> <br /> ==Route of Administration== <br /> <br /> Oral <br /> <br /> ==Dosages == <br /> <br /> For adults and children aged 12 years and older, the typical dosage is: <br /> <br /> Healing: 60 mg once daily for up to 8 weeks <br /> <br /> Maintenance: 30 mg once daily for up to 6 months <br /> <br /> GERD: 30 mg once daily for up to 4 weeks</div>

Calise https://www.sehk-wiki.org/index.php?title=Dexlansoprazole_(DEXILANT)&diff=5046 2025-01-06T06:22:49Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]][[Category: Proton Pump Inhibitors (PPI)]][[:Category: Gastrointestinal Drug | '''Gastrointestinal Drug''']] <br /> <br /> '''Drug class: [[:Category: Proton Pump Inhibitors (PPI) | Proton Pump Inhibitors (PPI)]]''' <br /> <br /> '''Dexlansoprazole''' (中文: [[右蘭索拉唑]]) <br /> <br /> ==Drug Class== <br /> <br /> Proton Pump Inhibitors (PPI) <br /> <br /> ==Common Strengths of Dexlansoprazole capsule== <br /> <br /> Dexlansoprazole capsule are available in the following strengths: <br /> <br /> *30 mg delayed-release capsules <br /> <br /> *60mg delayed-release capsules <br /> <br /> ==Drug Trade Names of Dexlansoprazole capsule== <br /> <br /> Dexilant <br /> <br /> ==Drug Usage== <br /> <br /> Dexlansoprazole is used for: <br /> <br /> *Healing of erosive esophagitis (EE) <br /> <br /> *Maintenance of healed erosive esophagitis (EE) <br /> <br /> *Treatment of gastroesophageal reflux disease (GERD) <br /> <br /> ==Mechanism of Action== <br /> <br /> Inhibits (H+/K+ )-ATPase enzyme in the gastric parietal cells, blocking gastric acid production in the stomach <br /> <br /> ==Route of Administration== <br /> <br /> Oral <br /> <br /> ==Dosages == <br /> <br /> For adults and children aged 12 years and older, the typical dosage is: <br /> <br /> Healing: 60 mg once daily for up to 8 weeks <br /> <br /> Maintenance: 30 mg once daily for up to 6 months</div>

Calise https://www.sehk-wiki.org/index.php?title=Dexlansoprazole_(DEXILANT)&diff=5045 2025-01-06T06:22:48Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]][[Category: Proton Pump Inhibitors (PPI)]][[:Category: Gastrointestinal Drug | '''Gastrointestinal Drug''']] <br /> <br /> '''Drug class: [[:Category: Proton Pump Inhibitors (PPI) | Proton Pump Inhibitors (PPI)]]''' <br /> <br /> '''Dexlansoprazole''' (中文: [[右蘭索拉唑]]) <br /> <br /> ==Drug Class== <br /> <br /> Proton Pump Inhibitors (PPI) <br /> <br /> ==Common Strengths of Dexlansoprazole capsule== <br /> <br /> Dexlansoprazole capsule are available in the following strengths: <br /> <br /> *30 mg delayed-release capsules <br /> <br /> *60mg delayed-release capsules <br /> <br /> ==Drug Trade Names of Dexlansoprazole capsule== <br /> <br /> Dexilant <br /> <br /> ==Drug Usage== <br /> <br /> Dexlansoprazole is used for: <br /> <br /> *Healing of erosive esophagitis (EE) <br /> <br /> *Maintenance of healed erosive esophagitis (EE) <br /> <br /> *Treatment of gastroesophageal reflux disease (GERD) <br /> <br /> ==Mechanism of Action== <br /> <br /> Inhibits (H+/K+ )-ATPase enzyme in the gastric parietal cells, blocking gastric acid production in the stomach <br /> <br /> ==Route of Administration== <br /> <br /> Oral <br /> <br /> ==Dosages == <br /> <br /> For adults and children aged 12 years and older, the typical dosage is: <br /> <br /> Healing: 60 mg once daily for up to 8 weeks</div>

Calise https://www.sehk-wiki.org/index.php?title=Dexlansoprazole_(DEXILANT)&diff=5044 2025-01-06T06:22:46Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]][[Category: Proton Pump Inhibitors (PPI)]][[:Category: Gastrointestinal Drug | '''Gastrointestinal Drug''']] <br /> <br /> '''Drug class: [[:Category: Proton Pump Inhibitors (PPI) | Proton Pump Inhibitors (PPI)]]''' <br /> <br /> '''Dexlansoprazole''' (中文: [[右蘭索拉唑]]) <br /> <br /> ==Drug Class== <br /> <br /> Proton Pump Inhibitors (PPI) <br /> <br /> ==Common Strengths of Dexlansoprazole capsule== <br /> <br /> Dexlansoprazole capsule are available in the following strengths: <br /> <br /> *30 mg delayed-release capsules <br /> <br /> *60mg delayed-release capsules <br /> <br /> ==Drug Trade Names of Dexlansoprazole capsule== <br /> <br /> Dexilant <br /> <br /> ==Drug Usage== <br /> <br /> Dexlansoprazole is used for: <br /> <br /> *Healing of erosive esophagitis (EE) <br /> <br /> *Maintenance of healed erosive esophagitis (EE) <br /> <br /> *Treatment of gastroesophageal reflux disease (GERD) <br /> <br /> ==Mechanism of Action== <br /> <br /> Inhibits (H+/K+ )-ATPase enzyme in the gastric parietal cells, blocking gastric acid production in the stomach <br /> <br /> ==Route of Administration== <br /> <br /> Oral <br /> <br /> ==Dosages == <br /> <br /> For adults and children aged 12 years and older, the typical dosage is:</div>

Calise https://www.sehk-wiki.org/index.php?title=Dexlansoprazole_(DEXILANT)&diff=5043 2025-01-06T06:22:45Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]][[Category: Proton Pump Inhibitors (PPI)]][[:Category: Gastrointestinal Drug | '''Gastrointestinal Drug''']] <br /> <br /> '''Drug class: [[:Category: Proton Pump Inhibitors (PPI) | Proton Pump Inhibitors (PPI)]]''' <br /> <br /> '''Dexlansoprazole''' (中文: [[右蘭索拉唑]]) <br /> <br /> ==Drug Class== <br /> <br /> Proton Pump Inhibitors (PPI) <br /> <br /> ==Common Strengths of Dexlansoprazole capsule== <br /> <br /> Dexlansoprazole capsule are available in the following strengths: <br /> <br /> *30 mg delayed-release capsules <br /> <br /> *60mg delayed-release capsules <br /> <br /> ==Drug Trade Names of Dexlansoprazole capsule== <br /> <br /> Dexilant <br /> <br /> ==Drug Usage== <br /> <br /> Dexlansoprazole is used for: <br /> <br /> *Healing of erosive esophagitis (EE) <br /> <br /> *Maintenance of healed erosive esophagitis (EE) <br /> <br /> *Treatment of gastroesophageal reflux disease (GERD) <br /> <br /> ==Mechanism of Action== <br /> <br /> Inhibits (H+/K+ )-ATPase enzyme in the gastric parietal cells, blocking gastric acid production in the stomach <br /> <br /> ==Route of Administration== <br /> <br /> Oral</div>

Calise https://www.sehk-wiki.org/index.php?title=Dexlansoprazole_(DEXILANT)&diff=5042 2025-01-06T06:22:43Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]][[Category: Proton Pump Inhibitors (PPI)]][[:Category: Gastrointestinal Drug | '''Gastrointestinal Drug''']] <br /> <br /> '''Drug class: [[:Category: Proton Pump Inhibitors (PPI) | Proton Pump Inhibitors (PPI)]]''' <br /> <br /> '''Dexlansoprazole''' (中文: [[右蘭索拉唑]]) <br /> <br /> ==Drug Class== <br /> <br /> Proton Pump Inhibitors (PPI) <br /> <br /> ==Common Strengths of Dexlansoprazole capsule== <br /> <br /> Dexlansoprazole capsule are available in the following strengths: <br /> <br /> *30 mg delayed-release capsules <br /> <br /> *60mg delayed-release capsules <br /> <br /> ==Drug Trade Names of Dexlansoprazole capsule== <br /> <br /> Dexilant <br /> <br /> ==Drug Usage== <br /> <br /> Dexlansoprazole is used for: <br /> <br /> *Healing of erosive esophagitis (EE) <br /> <br /> *Maintenance of healed erosive esophagitis (EE) <br /> <br /> *Treatment of gastroesophageal reflux disease (GERD) <br /> <br /> ==Mechanism of Action== <br /> <br /> Inhibits (H+/K+ )-ATPase enzyme in the gastric parietal cells, blocking gastric acid production in the stomach</div>

Calise https://www.sehk-wiki.org/index.php?title=Dexlansoprazole_(DEXILANT)&diff=5041 2025-01-06T06:22:42Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]][[Category: Proton Pump Inhibitors (PPI)]][[:Category: Gastrointestinal Drug | '''Gastrointestinal Drug''']] <br /> <br /> '''Drug class: [[:Category: Proton Pump Inhibitors (PPI) | Proton Pump Inhibitors (PPI)]]''' <br /> <br /> '''Dexlansoprazole''' (中文: [[右蘭索拉唑]]) <br /> <br /> ==Drug Class== <br /> <br /> Proton Pump Inhibitors (PPI) <br /> <br /> ==Common Strengths of Dexlansoprazole capsule== <br /> <br /> Dexlansoprazole capsule are available in the following strengths: <br /> <br /> *30 mg delayed-release capsules <br /> <br /> *60mg delayed-release capsules <br /> <br /> ==Drug Trade Names of Dexlansoprazole capsule== <br /> <br /> Dexilant <br /> <br /> ==Drug Usage== <br /> <br /> Dexlansoprazole is used for: <br /> <br /> *Healing of erosive esophagitis (EE) <br /> <br /> *Maintenance of healed erosive esophagitis (EE) <br /> <br /> *Treatment of gastroesophageal reflux disease (GERD)</div>

Calise https://www.sehk-wiki.org/index.php?title=Dexlansoprazole_(DEXILANT)&diff=5040 2025-01-06T06:22:39Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]][[Category: Proton Pump Inhibitors (PPI)]][[:Category: Gastrointestinal Drug | '''Gastrointestinal Drug''']] <br /> <br /> '''Drug class: [[:Category: Proton Pump Inhibitors (PPI) | Proton Pump Inhibitors (PPI)]]''' <br /> <br /> '''Dexlansoprazole''' (中文: [[右蘭索拉唑]]) <br /> <br /> ==Drug Class== <br /> <br /> Proton Pump Inhibitors (PPI) <br /> <br /> ==Common Strengths of Dexlansoprazole capsule== <br /> <br /> Dexlansoprazole capsule are available in the following strengths: <br /> <br /> *30 mg delayed-release capsules <br /> <br /> *60mg delayed-release capsules <br /> <br /> ==Drug Trade Names of Dexlansoprazole capsule== <br /> <br /> Dexilant <br /> <br /> ==Drug Usage== <br /> <br /> Dexlansoprazole is used for: <br /> <br /> *Healing of erosive esophagitis (EE) <br /> <br /> *Maintenance of healed erosive esophagitis (EE)</div>

Calise https://www.sehk-wiki.org/index.php?title=Dexlansoprazole_(DEXILANT)&diff=5039 2025-01-06T06:22:37Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]][[Category: Proton Pump Inhibitors (PPI)]][[:Category: Gastrointestinal Drug | '''Gastrointestinal Drug''']] <br /> <br /> '''Drug class: [[:Category: Proton Pump Inhibitors (PPI) | Proton Pump Inhibitors (PPI)]]''' <br /> <br /> '''Dexlansoprazole''' (中文: [[右蘭索拉唑]]) <br /> <br /> ==Drug Class== <br /> <br /> Proton Pump Inhibitors (PPI) <br /> <br /> ==Common Strengths of Dexlansoprazole capsule== <br /> <br /> Dexlansoprazole capsule are available in the following strengths: <br /> <br /> *30 mg delayed-release capsules <br /> <br /> *60mg delayed-release capsules <br /> <br /> ==Drug Trade Names of Dexlansoprazole capsule== <br /> <br /> Dexilant <br /> <br /> ==Drug Usage== <br /> <br /> Dexlansoprazole is used for: <br /> <br /> *Healing of erosive esophagitis (EE)</div>

Calise https://www.sehk-wiki.org/index.php?title=Dexlansoprazole_(DEXILANT)&diff=5038 2025-01-06T06:22:36Z

<p>Calise: </p> <hr /> <div>[[Category: Drugs]][[Category: Proton Pump Inhibitors (PPI)]][[:Category: Gastrointestinal Drug | '''Gastrointestinal Drug''']] <br /> <br /> '''Drug class: [[:Category: Proton Pump Inhibitors (PPI) | Proton Pump Inhibitors (PPI)]]''' <br /> <br /> '''Dexlansoprazole''' (中文: [[右蘭索拉唑]]) <br /> <br /> ==Drug Class== <br /> <br /> Proton Pump Inhibitors (PPI) <br /> <br /> ==Common Strengths of Dexlansoprazole capsule== <br /> <br /> Dexlansoprazole capsule are available in the following strengths: <br /> <br /> *30 mg delayed-release capsules <br /> <br /> *60mg delayed-release capsules <br /> <br /> ==Drug Trade Names of Dexlansoprazole capsule== <br /> <br /> Dexilant</div>

Calise